<SEC-DOCUMENT>0001104659-25-046715.txt : 20250509
<SEC-HEADER>0001104659-25-046715.hdr.sgml : 20250509
<ACCEPTANCE-DATETIME>20250509160405
ACCESSION NUMBER:		0001104659-25-046715
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250509
DATE AS OF CHANGE:		20250509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CENTRUS ENERGY CORP
		CENTRAL INDEX KEY:			0001065059
		STANDARD INDUSTRIAL CLASSIFICATION:	MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400]
		ORGANIZATION NAME:           	01 Energy & Transportation
		EIN:				522107911
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-272984
		FILM NUMBER:		25930256

	BUSINESS ADDRESS:	
		STREET 1:		6901 ROCKLEDGE DR
		STREET 2:		SUITE 800
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20817
		BUSINESS PHONE:		3015643200

	MAIL ADDRESS:	
		STREET 1:		6901 ROCKLEDGE DR
		STREET 2:		SUITE 800
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20817

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	USEC INC
		DATE OF NAME CHANGE:	19980629
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>tm2514263d1_424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule&nbsp;424(b)(5)<BR>
Registration No.&nbsp;333-272984</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PROSPECTUS SUPPLEMENT<BR>
(to the Prospectus dated July&nbsp;10, 2023)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to $200,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;<IMG SRC="tm2514263d1_424b5img001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Centrus Energy Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Class&nbsp;A Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This prospectus supplement is being filed to replace,
update, amend and supplement the prospectus supplement, dated February&nbsp;9, 2024 (the &ldquo;Prior Prospectus Supplement&rdquo;), filed
with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on February&nbsp;9, 2024, and the prospectus, dated July&nbsp;10,
2023, relating to the offer and sale of our Class&nbsp;A Common Stock, $0.10 par value per share (the &ldquo;Class&nbsp;A Common Stock&rdquo;),
from time to time through or to B. Riley Securities,&nbsp;Inc. (&ldquo;B. Riley&rdquo;), Lake Street Capital Markets, LLC (&ldquo;Lake
Street&rdquo;) and Roth Capital Partners, LLC (&ldquo;Roth&rdquo; and, together with B. Riley and Lake Street, the &ldquo;Agents&rdquo;;
each, an &ldquo;Agent&rdquo;) pursuant to the terms of the At Market Issuance Sales Agreement, dated as of February&nbsp;9, 2024 (the
 &ldquo;Sales Agreement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This prospectus supplement replaces, updates,
amends and supplements the Prior Prospectus Supplement by increasing the aggregate offering price of Class&nbsp;A Common Stock that may
offered and sold pursuant to the Sales Agreement to $200,000,000. As of the date of this prospectus supplement, we have sold shares of
our Class&nbsp;A Common Stock having an aggregate offering price of $82,881,274 pursuant to the Sales Agreement and the Prior Prospectus
Supplement. As a result, we may offer and sell up to an additional $117,118,726 aggregate offering price of Class&nbsp;A Common Stock
pursuant to the Sales Agreement and this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our Class&nbsp;A Common Stock is traded on the
NYSE American LLC (the &ldquo;NYSE&rdquo;) under the symbol &ldquo;LEU.&rdquo; The last reported sale price of our Class&nbsp;A Common
Stock on May&nbsp;8, 2025 was $88.46 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Sales of our Class&nbsp;A Common Stock, if any,
under this prospectus supplement will be made by any method permitted that is deemed an &ldquo;at the market offering&rdquo; as defined
in Rule&nbsp;415 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). The Agents are not required to sell
any specific amount of shares of our Class&nbsp;A Common Stock, but will act as our sales agents using commercially reasonable efforts
consistent with their normal trading and sales practices. There is no arrangement for funds to be received in any escrow, trust or similar
arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Agents will be entitled to compensation at
a commission rate up to 3.0% of the gross sales price per share of our Class&nbsp;A Common Stock sold. In connection with the sale of
our Class&nbsp;A Common Stock on our behalf, an Agent will be deemed to be an &ldquo;underwriter&rdquo; within the meaning of the Securities
Act and the compensation of the Agents will be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification
and contribution to the Agents with respect to certain liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>Investing in our Class&nbsp;A Common Stock
involves a high degree of risk. Before buying shares of our Class&nbsp;A Common Stock, you should carefully consider the risk factors
described in &ldquo;Risk Factors&rdquo; beginning on page&nbsp;S-4 of this prospectus supplement , the section captioned &ldquo;Item
1A&mdash;Risk Factors&rdquo; in our most recently filed Annual Report on Form&nbsp;10-K and subsequent Quarterly Reports on Form&nbsp;10-Q,
which are incorporated by reference into this prospectus supplement, and under similar headings in the other documents that are filed
after the date hereof and incorporated by reference into this prospectus supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>Neither the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
supplement is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B. Riley Securities</B></FONT></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lake Street</B></FONT></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Roth Capital Partners</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus supplement is May&nbsp;9,
2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding: 0.25pt 0.25pt 1.25pt 0.5pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt 0.25pt 1.25pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page&nbsp;</B></FONT></TD>
    <TD STYLE="padding: 0.25pt 0.25pt 1.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 87%; padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#pros_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT
    THIS PROSPECTUS SUPPLEMENT</FONT></A></TD>
    <TD STYLE="width: 1%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 10%; padding: 0.25pt; text-align: right"><A HREF="#pros_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-iii</FONT></A></TD>
    <TD STYLE="width: 1%; padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#pros_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPECIAL
    NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#pros_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-iv</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#pros_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS
    SUPPLEMENT SUMMARY</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#pros_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#pros_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE OFFERING</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#pros_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-3</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#pros_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#pros_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-4</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#pros_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF
    PROCEEDS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#pros_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-6</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#pros_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF
    DISTRIBUTION</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#pros_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-8</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#pros_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#pros_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-9</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#pros_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#pros_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-9</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#pros_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU
    CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#pros_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-9</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#pros_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION
    OF CERTAIN DOCUMENTS BY REFERENCE</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#pros_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-10</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 87%; border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 1.5pt 0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prospectus</B></FONT></TD>
    <TD STYLE="width: 1%; padding: 0.25pt 0.25pt 1.25pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt">&nbsp;</TD>
    <TD STYLE="width: 10%; border-bottom: black 1pt solid; padding: 0.25pt 0.25pt 0.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page&nbsp;</B></FONT></TD>
    <TD STYLE="width: 1%; padding: 0.25pt 0.25pt 1.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT THIS
    PROSPECTUS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU
    CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION
    WE INCORPORATE BY REFERENCE</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SPECIAL
    NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_004">4</A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CENTRUS
    ENERGY CORP.</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF
    PROCEEDS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
    OF CAPITAL STOCK</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
    OF DEBT SECURITIES</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
    OF WARRANTS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
    OF RIGHTS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
    OF UNITS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF
    DISTRIBUTION</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding: 0.25pt 0.25pt 0.25pt 0.5pt"><A HREF="#a_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; text-align: right"><A HREF="#a_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></A></TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pros_001"></A>ABOUT THIS PROSPECTUS SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This prospectus supplement and the accompanying
prospectus form part of a registration statement on Form&nbsp;S-3 that we filed with the SEC using a &ldquo;shelf&rdquo; registration
process. This document is in two parts. The first part is this prospectus supplement, which contains specific information about the terms
on which we are offering and selling our Class&nbsp;A Common Stock and important business information about us. The second part is the
accompanying prospectus, which contains and incorporates by reference important business and financial information about us and other
information about this offering. This prospectus supplement and the accompanying prospectus are part of a shelf registration statement
that we filed with the SEC under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In making your investment decision, you should
rely only on the information contained in or incorporated by reference in this prospectus supplement, the accompanying prospectus and
any free writing prospectus filed by us with the SEC. We are responsible for the information contained in this prospectus supplement and
the accompanying prospectus, including the information incorporated by reference herein as described herein and therein, and any free
writing prospectus that we prepare and distribute. Neither we nor the Agents have authorized anyone to provide you with information different
from that contained in or incorporated by reference into this prospectus supplement, the accompanying prospectus or any such free writing
prospectus. Neither we nor the Agents are making an offer to sell, or soliciting an offer to buy, these securities in any jurisdiction
where the offer or sale is not permitted. The information contained or incorporated by reference in this prospectus supplement, the accompanying
prospectus or any related free writing prospectus prepared by us is accurate only as of the date of the applicable document. Our business,
financial condition, results of operations and prospects may have changed since that date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This prospectus supplement and the accompanying
prospectus do not contain all of the information included in the registration statement as permitted by the rules&nbsp;and regulations
of the SEC. For further information, we refer you to the registration statement on Form&nbsp;S-3, including its exhibits, of which this
prospectus supplement and the accompanying prospectus form a part. We are subject to the informational requirements of the Securities
Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), and therefore file reports and other information with the SEC. Statements
contained in this prospectus supplement and the accompanying prospectus about the provisions or contents of any agreement or other document
are only summaries. If SEC rules&nbsp;require that any agreement or document be filed as an exhibit to the registration statement, you
should refer to that agreement or document for its complete contents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Before you invest in our Class&nbsp;A Common Stock,
you should read the registration statement of which this document forms a part and this document, including the documents incorporated
by reference in this prospectus supplement and the accompanying prospectus that are described under the caption &ldquo;Where You Can Find
More Information&rdquo; in this prospectus supplement and the accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the description of this offering and our business
varies between this prospectus supplement and the accompanying prospectus, you should rely on the information in this prospectus supplement.
Any statement made in this prospectus supplement or in a document incorporated or deemed to be incorporated by reference in this prospectus
supplement will be deemed to be modified or superseded for purposes of this prospectus supplement to the extent that a statement contained
in this prospectus supplement or in any other subsequently filed document that is also incorporated or deemed to be incorporated by reference
in this prospectus supplement modifies or supersedes that statement. Any statement so modified or superseded will not be deemed, except
as so modified or superseded, to constitute a part of this prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Unless otherwise expressly indicated or the context
otherwise requires, we use the terms &ldquo;Centrus,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our&rdquo;
or similar references to refer to Centrus Energy Corp. and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pros_002"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">This prospectus supplement, including the documents
incorporated by reference herein, may contain or incorporate &ldquo;forward-looking statements&rdquo; within the meaning of Section&nbsp;21E
of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking
statements mean statements related to future events, which may impact our expected future business and financial performance, and often
contain words such as &ldquo;expects&rdquo;, &ldquo;anticipates&rdquo;, &ldquo;intends&rdquo;, &ldquo;plans&rdquo;, &ldquo;believes&rdquo;,
 &ldquo;will&rdquo;, &ldquo;should&rdquo;, &ldquo;could&rdquo;, &ldquo;would&rdquo; or &ldquo;may&rdquo; and other words of similar meaning.
Forward-looking statements by their nature address matters that are, to different degrees, uncertain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For Centrus, particular risks and uncertainties
(hereinafter &ldquo;risks&rdquo;) that could cause our actual future results to differ materially from those expressed in our forward-looking
statements include but are not limited to the following and which are, and may be, exacerbated by any worsening of the global business
and economic environment include but are not limited to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
related to the war in Ukraine</FONT> primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to geopolitical conflicts and the imposition of sanctions or other measures, including
bans or tariffs, by (i)&nbsp;the U.S. or foreign governments and institutions such as the EU, (ii)&nbsp;organizations (including the United
Nations or other international organizations), or (iii)&nbsp;entities (including private entities or persons), that could directly or
indirectly impact our financial position or ability to obtain, deliver, transport, or sell low enriched uranium (&ldquo;LEU&rdquo;) or
the separate work units (&ldquo;SWU&rdquo;) and natural uranium hexafluoride components of LEU delivered to us under the TENEX Supply
Contract or other supply contracts or make related payments or deliveries of natural uranium hexafluoride to TENEX, Joint Stock Company
(&ldquo;TENEX&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to laws or other government measures that ban, delay or restrict (i)&nbsp;imports
of Russian LEU into the United States, including but not limited to the Import Ban Act, or (ii)&nbsp;transactions with Rosatom or its
subsidiaries, which include TENEX or (iii)&nbsp;exports of Russian LEU from Russia to the United States or any entity that is a U.S. entity
or that transacts with a U.S. entity, including but not limited to the Russian Decree;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to our potential inability to secure additional U.S. government waivers from the
Import Ban Act in a timely manner or at all in order to allow us to continue importing Russian LEU under the TENEX Supply Contract or
implementing the TENEX Supply Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to TENEX&rsquo;s refusal or its prohibition or inability to deliver, or timely
deliver, LEU to us for any reason including (i)&nbsp;U.S. or foreign government sanctions, bans, or decrees imposed on LEU from Russia
or on TENEX, (ii)&nbsp;TENEX being unable, prohibited or unwilling to receive payments, receive the return of natural uranium hexafluoride,
or conduct other activities related to the TENEX Supply Contract, (iii)&nbsp;TENEX electing, or being directed (including by its owner
or the Russian government), to limit, pause or stop transactions with us or with the United States or other countries or (iv)&nbsp;TENEX
being unable to secure specific export licenses from the Russian authorities as required by the Russian Decree for each shipment or secure
them in a timely manner to ship Russian LEU to the United States, or such export licenses, once secured, are subsequently rescinded prior
to shipment;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to laws, sanctions or other government measures that prohibit or restrict doing
business with TENEX; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to disputes with third parties, including contractual counterparties, that could
result if we do not receive timely deliveries of LEU under the TENEX Supply Contract and are unable to rely on contractual protections.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
related to economic and industry factors</FONT> primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to our dependence on others, such as TENEX, under the TENEX Supply Contract, Orano,
under the Orano Supply Agreement, and other suppliers (including, but not limited to, transporters, fabricators or converters) who provide,
or deliver, us the goods and services we need to conduct our business and any resulting negative impact on our liquidity;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to our ability to sell, transport or deliver the LEU we procure pursuant to our
purchase obligations under our supply agreements and the impacts of sanctions or limitations on imports of such LEU, including those imposed
under the RSA, international trade legislation and other international trade restrictions including but not limited to the Import Ban
Act and Russian Decree;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the increasing quantities of LEU being imported into the United States from
China and the impact on our ability to make future LEU or SWU sales or ability to finance any build out of our enrichment capacities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risk related to change in laws, tariffs or other government measures that would lift, lower
or relax such laws, tariffs or government measures to allow the importation of LEU, or increase its cost, from Russia or other countries
with restrictions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to not being able to sell the Russian LEU we may be allowed to import in 2026
or 2027 for any reason, even if we secure waivers, including customers having filled their fuel needs for those years;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to whether or when government funding or demand for HALEU for government or commercial
uses will materialize and at what level;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks regarding funding for continuation and deployment of the American Centrifuge technology;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to (i)&nbsp;our ability to perform and absorb costs under the HALEU Operation
Contract, (ii)&nbsp;our ability to obtain new contracts and funding to be able to continue operations and (iii)&nbsp;our ability to obtain
and/or perform under other agreements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks that (i)&nbsp;we may not obtain the full benefit of the HALEU Operation Contract and may
not be able or allowed to operate the HALEU enrichment facility to produce HALEU after the completion of the HALEU Operation Contract
or (ii)&nbsp;the output from the HALEU enrichment facility may not be available to us as a future source of supply;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to existing or new trade barriers, and related to contract terms, that limit our
ability to procure LEU for, or sell, transport or deliver LEU to, customers;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to pricing trends and demand in the uranium and enrichment markets and their impact
on our profitability;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the movement and timing of customer orders;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the fact that we face significant competition from major LEU producers who
may be less cost sensitive or are wholly or partially government owned;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks that our ability to compete in foreign markets may be limited for various reasons, including
policies that favor indigenous suppliers over foreign suppliers of goods and services;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the fact that our revenue is largely dependent on our largest customers;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to our backlog, including uncertainty concerning customer actions under current
contracts and in future contracting attributable to market conditions, global events or other factors, including our lack of current production
capability;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to natural and other disasters, including the continued impact of the March&nbsp;2011
earthquake and tsunami in Japan, on the nuclear industry and on our business, results of operations and prospects;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to financial difficulties experienced by customers or suppliers, including possible
bankruptcies, insolvencies, or any other situation, event or occurrence that affect the ability of others to pay for our products or services
in a timely manner or at all;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to pandemics, endemics, and other health crises; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the impact and potential extended duration of a supply/demand imbalance in
the market for LEU.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
related to operational factors</FONT> primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 12px; font-size: 10pt"><FONT STYLE="font-size: 10pt; background-color: white">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt; background-color: white">risks related to the Department of Energy (&ldquo;DOE&rdquo;) not issuing any major task orders to any contract awardee under any of the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the Company not winning a task order under the HALEU Production Contract, LEU
Production Contract and HALEU Deconversion Contract to expand the capacity of the American Centrifuge plant;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to DOE not providing an adequate share of the appropriated funding to the
                                                                                                                                                                          Company under any of the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to our ability to secure financing to expand our plant for LEU or HALEU or expand
it to the level that would make it commercially viable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the DOE not exercising options following the completion of Phase 2 of the HALEU
Operation Contract or awarding a third party to continue the HALEU Operation Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to our inability to increase capacity for HALEU or LEU in a timely manner to meet
market demand or our contractual obligations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to DOE not awarding any contracts to the Company in response to the Company&rsquo;s
future proposals;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt">&#9679;</TD><TD><FONT STYLE="background-color: white">risks related to reliance on the only firm that has the necessary permits and capability to
transport LEU from Russia to the United States and that firm&rsquo;s ability to maintain those permits and capabilities or secure additional
permits;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to a government shutdown or lack of funding that could result in program cancellations,
disruptions and/or stop work orders and could limit the U.S. government&rsquo;s ability to make timely payments, including under Executive
Order 14158, and our ability to perform our U.S. government contracts and successfully compete for work including under the HALEU Operation
Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to changes to the U.S. government&rsquo;s appropriated funding levels for the
HALEU Operation Contract due to changes in U.S. government policy or other reasons;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to uncertainty regarding our ability to commercially deploy competitive enrichment
technology;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the potential for demobilization or termination of the HALEU Operation Contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks that we will not be able to timely complete the work that we are obligated to perform;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the government&rsquo;s inability to satisfy its obligations, including supplying
government furnished equipment necessary for us to produce and deliver HALEU under the HALEU Operation Contract and processing security
clearance applications resulting from a government shutdown or other reasons;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to our inability to obtain the government&rsquo;s approval to extend the term
of, or the scope of permitted activities under, our lease with the DOE in Piketon, Ohio;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to cybersecurity incidents that may impact our business operations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to our inability to perform fixed-price and cost-share contracts such as the HALEU
Operation Contract, including the risk that costs that we must bear could be higher than expected and the risk related to complying with
stringent government contractual requirements; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to our inability to attract qualified employees necessary for the potential expansion
of our operations in Oak Ridge, Tennessee or Piketon, Ohio.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
related to financial factors</FONT> primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to our long-term liabilities, including our defined benefit pension plan obligations
and postretirement health and life benefit obligations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to our 2.25% Convertible Notes maturing in 2030;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks of revenue and operating results fluctuating significantly from quarter to quarter, and
in some cases, year to year;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the impact of financial market conditions on our business, liquidity, prospects,
pension assets and insurance facilities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the Company&rsquo;s capital concentration;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the value of our intangible assets related to the LEU segment&rsquo;s backlog
and customer relationships;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to decisions made by our Class&nbsp;B Common Stock stockholders regarding their
investment in the Company, including decisions based upon factors that are unrelated to the Company&rsquo;s performance;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks that a small number of holders of our Class&nbsp;A Common Stock (whose interests may not
be aligned with other holders of our Class&nbsp;A Common Stock) may exert significant influence over the direction of the Company and
may be motivated by interests that are not aligned with the Company&rsquo;s other Class&nbsp;A stockholders;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to (i)&nbsp;the use of our net operating losses (&ldquo;NOLs&rdquo;) carryforwards
and net unrealized built in losses (&ldquo;NUBILs&rdquo;) to offset future taxable income and the use of the Rights Agreement to prevent
an &ldquo;ownership change&rdquo; as defined in Section&nbsp;382 of the Internal Revenue Code and (ii)&nbsp;our ability to generate taxable
income to utilize all or a portion of the NOLs prior to the expiration thereof and NUBILs; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to failures or security, including cybersecurity, breaches of our information
technology systems.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
related to general factors</FONT> primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to our ability to attract and retain key personnel;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks that we will be unable to obtain new business opportunities or achieve market acceptance
of our products and services or that products or services provided by others will render our products or services obsolete or noncompetitive;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to actions, including investigations, reviews or audits, that may be taken by
the U.S. government, the Russian government, or other governments that could affect our ability to perform under our contractual obligations
or the ability of our sources of supply to perform under their contractual obligations to us;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to our inability to perform and receive timely payment under our agreements with
the DOE or other government agencies, including risks related to the ongoing funding by the government and potential audits;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to how aligned we may be, or perceived to be, with any political party, administration,
or its policies based on our positions or our political action committee&rsquo;s advocacy;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to changes or termination of our agreements with the U.S. government or other
counterparties, or the exercise of contract remedies by such counterparties;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the competitive environment for our products and services;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to changes in the nuclear energy industry;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the competitive bidding process associated with obtaining contracts, including
government contracts; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to potential strategic transactions that could be difficult to implement, that
could disrupt our business or that could change our business profile significantly.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
related to legal and compliance factors</FONT> primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the outcome of legal proceedings and other contingencies (including lawsuits
and government investigations or audits);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the impact of, or changes to, government regulation and policies or interpretation
of laws or regulations, including by the DOE, DOC and the NRC;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks related to the recent U.S. federal government administration&rsquo;s reliance on executive
orders to implement regulatory or trade policy and objectives, which could exacerbate regulatory or, private or public, financing unpredictability;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks of accidents during the transportation, handling, or processing of toxic hazardous or
radioactive material that may pose a health risk to humans or animals, cause property or environmental damage, or result in precautionary
evacuations, and lead to claims against the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">risks associated with claims and litigation arising from past activities at sites we currently
operate or past activities at sites that we no longer operate, including the Paducah GDP and Portsmouth GDP; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">other risks discussed in this and our other filings with the SEC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">These factors may not constitute all factors that
could cause actual results to differ from those discussed in any forward-looking statement. All written and oral forward-looking statements
attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements disclosed
under &ldquo;Item 1A. Risk Factors,&rdquo; in our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024 and our Quarterly
Report on Form&nbsp;10-Q for the quarterly period ended March&nbsp;31, 2025, as such risk factors may be amended, supplemented or superseded
from time to time by other reports we file with the SEC, including subsequent Annual Reports on Form&nbsp;10-K and Quarterly Reports on
Form&nbsp;10-Q, and in any subsequent prospectus supplement. Accordingly, forward-looking statements should not be relied upon as a predictor
of actual results. Readers are urged to carefully review and consider the various disclosures made in this report and in our other filings
with the SEC that attempt to advise interested parties of the risks and factors that may affect our business. We do not undertake to update
our forward-looking statements to reflect events or circumstances that may arise after the date of this prospectus supplement, except
as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<DIV STYLE=" border: Black 1pt solid; padding-right: 6pt; padding-left: 6pt; padding-top: 8pt; padding-bottom: 8pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pros_003"></A>PROSPECTUS SUPPLEMENT
SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>This summary highlights
the information contained elsewhere in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference
herein and therein and is qualified in its entirety by reference to the more detailed information and financial statements appearing elsewhere
in this prospectus supplement. Because this is only a summary, it does not contain all of the information that may be important to you.
Before investing in our Class&nbsp;A Common Stock, you should read this entire prospectus supplement, the accompanying prospectus and
any related free writing prospectus, together with all documents incorporated by reference herein and therein, carefully, including the
 &ldquo;Risk Factors&rdquo; section of this prospectus supplement, in our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000006/leu-20241231.htm">Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024</A> and our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000024/leu-20250331.htm">Quarterly Report on Form&nbsp;10-Q for the quarter ended March&nbsp;31, 2025</A>, as such risk factors may be amended, supplemented
or superseded from time to time by other reports we file with the SEC, including subsequent Annual Reports on Form&nbsp;10-K and Quarterly
Reports on Form&nbsp;10-Q, and in any subsequent prospectus supplement, and our consolidated financial statements and related notes incorporated
by reference in this prospectus supplement, before making an investment decision.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Centrus is a trusted
supplier of nuclear fuel components for the nuclear power industry, which provides a reliable source of carbon free energy and provides
enrichment and technical services for public and private customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Centrus operates two
business segments: (a)&nbsp;LEU, which supplies various components of nuclear fuel to commercial customers from our global network of
suppliers, and (b)&nbsp;Technical Solutions, which provides advanced uranium enrichment for the nuclear industry and the U.S. government
and advanced manufacturing and other technical services to government and private sector customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our LEU segment currently
provides most of the Company&rsquo;s revenue and involves the sale of enriched uranium, the fissile component of nuclear fuel, primarily
to utilities that operate commercial nuclear power plants. The majority of these sales are for the enrichment component of LEU, which
is measured in SWU. Centrus also sells natural uranium hexafluoride (the raw material needed to produce LEU) and occasionally sells uranium
concentrates, uranium conversion, or LEU with the natural uranium hexafluoride and SWU components combined into one sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">LEU is a critical component
in the production of nuclear fuel for reactors that produce electricity. We supply LEU and its components to both domestic and international
utilities for use in nuclear reactors worldwide. We provide LEU from multiple sources, including medium- and long-term supply contracts,
and spot purchases and our inventory. As a long-term supplier of LEU to our customers, our objective is to provide value through the reliability
and diversity of our supply sources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Published spot price
indicators for SWU reached previous historic highs in April&nbsp;2009 at $163 per SWU. In the years following the 2011 Fukushima accident
in Japan, spot prices declined more than 75%, bottoming out in August&nbsp;2018 at $34 per SWU. This was followed by a period of price
increases, which reached $195 per SWU by December&nbsp;31, 2024, which surpassed the previous historic high. As of March&nbsp;31, 2025,
spot prices were $190 per SWU. This represents a decrease of 3% since the beginning of the year but an increase of 459% over the 2018
historic low. This surge in the SWU spot price beginning in 2022 has been driven primarily by uncertainty created as a result of the war
in Ukraine, coupled with growing interest in nuclear power as a source of reliable carbon-free energy. The contemplation of imposition
of tariffs on LEU, if ultimately imposed, may put additional upward pressure on the spot price of SWU.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">When Russian supply is
included, the uranium enrichment segment of the global nuclear fuel market is oversupplied. But without Russian supply, the global market
for uranium enrichment would be undersupplied. Further, it is not clear that there are sufficient inventories of enriched uranium in the
United States to compensate for a loss of Russian supply, absent new capacity that will take a number of years to deploy. A report issued
by the International Atomic Energy Agency in 2023 reported that while U.S. utilities may have enough inventory to cover one reload of
their reactors, &ldquo;truly strategic physical stockpiles are almost non-existent.&rdquo;</P>
</DIV>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<DIV STYLE=" border: Black 1pt solid; padding-right: 6pt; padding-left: 6pt; padding-top: 8pt; padding-bottom: 8pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Changes in the supply-demand
balance and in the competitive landscape arising from the war in Ukraine or the imposition of tariffs may affect pricing trends, change
customer spending patterns, and create additional uncertainty in the uranium market. At the same time, uncertainty remains about future
demand for nuclear power generation. To address such changes and uncertainty, we continue to evaluate opportunities to grow our business
organically or through acquisitions and other strategic transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our Technical Solutions
segment is committed to the restoration of America&rsquo;s domestic uranium enrichment production capability in order to play a critical
role in meeting U.S. national security and energy security requirements and advancing America&rsquo;s nonproliferation, energy, and climate
objectives. Our Technical Solutions segment is also focused on repairing broken and vulnerable supply chains, providing clean energy jobs,
and supporting the communities in which we operate. Our goal is to deliver major components of the next-generation nuclear fuels that
will provide reliable carbon-free power around the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are also actively
considering and expect to consider potential strategic transactions from time to time, which could involve, without limitation, acquisitions
and/or dispositions of businesses or assets, joint ventures or investments in businesses, products or technologies or changes to our capital
structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our principal executive
office is located at 6901 Rockledge Drive, Suite&nbsp;800, Bethesda, Maryland 20817, and our telephone number is (301) 564-3200. Our website
is www.centrusenergy.com. The information located on, or accessible from, our website is not, and should not be deemed to be, part of
this prospectus supplement or incorporated into any other filing that we submit to the SEC.</P>
</DIV>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<DIV STYLE=" border: Black 1pt solid; padding-right: 6pt; padding-left: 6pt; padding-top: 8pt; padding-bottom: 8pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pros_004"></A>THE OFFERING</B></P>
</DIV>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class&nbsp;A Common Stock offered by us pursuant to this prospectus supplement</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 50%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of our Class&nbsp;A Common Stock having an aggregate offering price of up to $</FONT>200,000,000, of which $117,118,726 remains available for sale.</TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class&nbsp;A Common Stock to be outstanding after this offering</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up to </FONT>17,642,040 shares, assuming sales at a price of $88.46 per share, which was the closing price on the NYSE on May&nbsp;8, 2025. The actual number of shares issued will vary depending on the sales price under any offering from time to time.</TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manner of offering</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;At the market
    offering&rdquo; that may be made  from time to time on the NYSE or other market for our Class&nbsp;A Common Stock in the United
    States through or to an Agent, as sales agent or principal. See the section entitled &ldquo;Plan of Distribution&rdquo;
    below.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of proceeds</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We intend to use the net proceeds for general working capital and corporate purposes, which may include investment in technology development and deployment, repayment or repurchase of outstanding debt, capital expenditures, potential acquisitions and other business opportunities and purposes. See the section entitled &ldquo;Use of Proceeds&rdquo; below.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk factors</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See &ldquo;Risk Factors&rdquo; beginning on page&nbsp;S-4 and the other information included in, or incorporated by reference into, this prospectus supplement for a discussion of certain factors you should carefully consider before deciding to invest in shares of our Class&nbsp;A Common Stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NYSE symbol</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEU</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pros_005"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>Investing in our Class&nbsp;A Common Stock
involves a high degree of risk. You should carefully consider the following risk factors, as well as other information in this prospectus
supplement, the accompanying prospectus and the documents incorporated by reference in this prospectus supplement, including the factors
discussed under the heading &ldquo;Risk Factors&rdquo; in our most recent Annual Report on Form&nbsp;10-K and each subsequently filed
Quarterly Report on Form&nbsp;10-Q and any risk factors set forth in our other filings with the SEC pursuant to Sections 13(a), 13(c),
14 or 15(d)&nbsp;of the Exchange Act, before deciding whether to invest in shares of our Class&nbsp;A Common Stock. See &ldquo;Where You
Can Find More Information&rdquo; and &ldquo;Information We Incorporate By Reference.&rdquo; The occurrence of any of the events described
below could harm our business, financial condition, results of operations and growth prospects. In such an event, the trading price of
our Class&nbsp;A Common Stock may decline, and you may lose all or part of your investment.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Additional Risks Related to This Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We will have broad discretion in the use of the net proceeds
from this offering and, despite our efforts, we may use the net proceeds in a manner that does not increase the value of your investment.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We intend to use the net proceeds from the sale
of shares of our Class&nbsp;A Common Stock in this offering for general working capital and corporate purposes, which may include investment
in technology development and deployment, repayment or repurchase of outstanding debt, capital expenditures, potential acquisitions and
other business opportunities and purposes. We retain broad discretion over the use of the net proceeds from the sale of shares of Class&nbsp;A
Common Stock and, accordingly, you will need to rely upon the judgment of our board of directors and management with respect to the use
of proceeds, potentially with only limited information concerning our specific intentions. These proceeds could be applied in ways that
do not improve our operating results or increase the value of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The actual number of shares we may issue under the Sales Agreement,
at any one time or in total, is uncertain and you may experience future dilution as a result of future equity offerings.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Subject to certain limitations in the Sales Agreement
and compliance with applicable law, we have the discretion to deliver a sales notice to an Agent at any time throughout the term of the
Sales Agreement. The number of shares that are sold by the Agents after delivering a sales notice, if any, will fluctuate based on the
market price of the Class&nbsp;A Common Stock during the sales period and limits we set with the Agents. Because the price per share of
each share sold will fluctuate based on the market price of our Class&nbsp;A Common Stock during the sales period, it is not possible
at this stage to predict the number of shares that will be ultimately issued. In addition, in order to raise additional capital, we may
offer in the future additional shares of our Class&nbsp;A Common Stock or other securities convertible into or exchangeable for our Class&nbsp;A
Common Stock at prices that may not be the same as the price per share in this offering. We may sell shares or other securities in any
other offering at a price per share that is less than the price per share paid by investors in this offering, and investors purchasing
shares or other securities in the future could have rights superior to existing stockholders. The price per share at which we sell additional
shares of our Class&nbsp;A Common Stock, or securities convertible or exchangeable into Class&nbsp;A Common Stock, in future transactions
may be higher or lower than the price per share paid by investors in this offering<B><I>.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our governing documents and Delaware law could prevent a takeover
that stockholders consider favorable and could also reduce the market price of our stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our certificate of incorporation, bylaws and the
Section&nbsp;382 Rights Agreement we have adopted with respect to our Class&nbsp;A Common Stock contain certain provisions that could
delay or prevent a change in control. These provisions could also make it more difficult for stockholders to elect directors and take
other corporate actions. These provisions include, without limitation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD>a requirement that stockholders must provide advance notice to propose nominations or have other business considered at a meeting
of stockholders;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD>supermajority stockholder approval to amend our bylaws or certain provisions in our certificate of incorporation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD>limitations on transferability; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD>authorization of blank check preferred stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, we are subject to the provisions
of Section&nbsp;203 of the Delaware General Corporation Law. These provisions may prohibit large stockholders, in particular those owning
15% or more of our outstanding Class&nbsp;A Common Stock, from engaging in certain business combinations without the approval of substantially
all of our stockholders for a certain period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">These and other provisions in our certificate
of incorporation, bylaws and under Delaware law, including restrictions on foreign ownership and restrictions set forth in the Section&nbsp;382
Rights Agreement, could discourage potential takeover attempts, reduce the price that investors might be willing to pay for shares of
our Class&nbsp;A Common Stock in the future and result in the market price being lower than it would be without these provisions. For
more information, see &ldquo;Description of Capital Stock&mdash; Provisions of the Company&rsquo;s Certificate of Incorporation, Bylaws
and Delaware Law that May&nbsp;Have an Anti-Takeover Effect&rdquo; in the accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pros_006"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The amount of proceeds from this offering will
depend upon the number of shares of our Class&nbsp;A Common Stock sold and the market price at which they are sold. There can be no assurance
that we will be able to sell any shares under or fully utilize the Sales Agreement with the Agents as a source of financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use the net proceeds for general working capital and corporate purposes, which may include investment in technology development
or deployment, repayment or repurchase of outstanding debt, capital expenditures, potential acquisitions and other business opportunities
and purposes</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The precise amount, use and timing of the application
of such proceeds will depend upon our funding requirements and the availability and cost of other capital. Pending application of the
net proceeds as described above, we intend to invest the net proceeds of the offering in short-term, investment-grade, interest-bearing
securities and/or savings accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pros_008"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have entered into a Sales Agreement with
the Agents  under which we may issue and sell our Class&nbsp;A Common Stock from time to time to or through the Agents
acting as sales agents or principals. Sales of shares of our Class&nbsp;A Common Stock, if any, under this prospectus supplement and
the accompanying prospectus may be made by any method that is deemed an &ldquo;at the market offering&rdquo; as defined in
Rule&nbsp;415 promulgated under the Securities Act. We may instruct the Agents not to sell Class&nbsp;A Common Stock if the sales
cannot be effected at or above the price designated by us from time to time. We or any of the Agents may suspend the offering of
Class&nbsp;A Common Stock upon notice and subject to other conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Agents will offer our Class&nbsp;A Common
Stock subject to the terms and conditions of the Sales Agreement as agreed upon by us and the Agents. Each time we wish to issue and sell
Class&nbsp;A Common Stock under the Sales Agreement, we will notify an Agent of the number or dollar value of shares to be issued, the
time period during which such sales are requested to be made, any limitation on the number of shares that may be sold in one day, any
minimum price below which sales may not be made and other sales parameters as we deem appropriate. Once we have so instructed an Agent,
unless the Agent declines to accept the terms of the notice, the Agents have agreed to use their commercially reasonable efforts consistent
with their normal trading and sales practices to sell such shares up to the amount specified on such terms. The obligations of the Agents
under the Sales Agreement to sell our Class&nbsp;A Common Stock are subject to a number of conditions that we must meet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We will pay the Agents commissions for their services
in acting as agents in the sale of our Class&nbsp;A Common Stock at a commission rate up to 3.0% of the gross sales price per share sold.
We have agreed to reimburse the legal expenses of the Agents in an amount not to exceed $50,000 in connection with the filing of this
prospectus supplement, in addition to certain ongoing disbursements of their legal counsel. Because there is no minimum offering amount
required as a condition to close this offering, the actual total public offering amount, commissions and proceeds to us, if any, are not
determinable at this time.&nbsp; We estimate that the total expenses for the offering, excluding commissions payable or fees reimbursable
to the Agents under the terms of the Sales Agreement, will be approximately $250,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Settlement for sales of Class&nbsp;A Common Stock
will generally occur on the first business day following the date on which any sales are made, or on some other date that is agreed upon
by us and the designated Agent in connection with a particular transaction, in return for payment of the net proceeds to us. There is
no arrangement for funds to be received in an escrow, trust or similar arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In connection with the sale of the Class&nbsp;A
Common Stock on our behalf, an Agent will be deemed to be an &ldquo;underwriter&rdquo; within the meaning of the Securities Act and the
compensation of the Agents will be deemed to be underwriting commissions or discounts. We have agreed to provide indemnification and contribution
to the Agents against certain civil liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The offering of our Class&nbsp;A Common Stock
pursuant to the Sales Agreement will terminate upon the earlier of (i)&nbsp;the sale of all of our Class&nbsp;A Common Stock subject to
the Sales Agreement, or (ii)&nbsp;termination of the Sales Agreement as provided therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>Additional Relationships</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Agents and their respective affiliates may
in the future provide various investment banking and other financial services for us and our affiliates, for which services they may in
the future receive customary fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pros_009"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The validity of the securities we are offering
will be passed upon by O&rsquo;Melveny&nbsp;&amp; Myers LLP. The Agents are being represented in connection with this offering by Duane
Morris LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pros_010"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The financial statements of Centrus Energy Corp.
as of December&nbsp;31, 2024 and 2023, and for each of the two years in the period ended December&nbsp;31, 2024, incorporated by reference
in this Prospectus by reference to Centrus Energy Corp.&rsquo;s <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000006/leu-20241231.htm">annual report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024</A>,
and the effectiveness of Centrus Energy Corp.&rsquo;s internal control over financial reporting have been audited by Deloitte&nbsp;&amp;
Touche LLP, an independent registered public accounting firm, as stated in their reports. Such financial statements are incorporated by
reference in reliance upon the reports of such firm given their authority as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The financial statements for the year in the period
ended December&nbsp;31, 2022 incorporated in this Prospectus by reference to the <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000006/leu-20241231.htm">Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024</A> have been so incorporated in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm,
given on the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pros_011"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have filed with the SEC, Washington, D.C. 20549,
a registration statement on Form&nbsp;S-3 under the Securities Act with respect to the Class&nbsp;A Common Stock offered hereby. This
prospectus supplement does not contain all of the information set forth in the registration statement and the exhibits and schedules thereto.
For further information with respect to the Company and its Class&nbsp;A Common Stock, reference is made to the registration statement
and the exhibits and any schedules filed therewith. Statements contained in this prospectus supplement as to the contents of any contract
or other document referred to are not necessarily complete and in each instance, if such contract or document is filed as an exhibit,
reference is made to the copy of such contract or other document filed as an exhibit to the registration statement, each statement being
qualified in all respects by such reference. Information on the operation of the Public Reference Room may be obtained by calling the
SEC at 1-800-SEC-0330. The SEC maintains an Internet site at www.sec.gov, from which interested persons can electronically access the
registration statement, including the exhibits and any schedules thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We are subject to the information reporting requirements
of the Exchange Act, and we file periodic reports and other information with the SEC. All documents filed with the SEC are available for
inspection and copying at the addresses set forth above. We also maintain an Internet site at www.centrusenergy.com. Our website and the
information contained therein or connected thereto shall not be deemed to be incorporated into this prospectus supplement or the registration
statement of which it forms a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pros_012"></A>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The SEC allows us to &ldquo;incorporate by reference&rdquo;
the information we file with them which means that we can disclose important information to you by referring you to those documents instead
of having to repeat the information in this prospectus supplement. The information incorporated by reference is considered to be part
of this prospectus supplement, and later information that we file with the SEC will automatically update and supersede this information.
This prospectus supplement incorporates by reference the documents listed below (other than, unless otherwise specifically indicated,
current reports furnished under Item 2.02,&nbsp;Item 7.01 or Item 9.01 of Form&nbsp;8-K and exhibits filed on such form that are related
to such items):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Wingdings; font-size: 10pt;">&sect;</FONT></TD>
    <TD><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000006/leu-20241231.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2024 (filed with the SEC on February&nbsp;7, 2025);</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Wingdings; font-size: 10pt;">&sect;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the information specifically incorporated by reference into our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000006/leu-20241231.htm">Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024</A> from our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000110465925039220/tm252408-1_def14a.htm">Definitive Proxy Statement on Schedule 14A (filed with the SEC on April&nbsp;25, 2025)</A>; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Wingdings; font-size: 10pt;">&sect;</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000024/leu-20250331.htm">Quarterly Report on Form&nbsp;10-Q for the quarter ended March&nbsp;31, 2025 (filed with the SEC on May&nbsp;8, 2025)</A>; and</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Wingdings; font-size: 10pt;">&sect;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Current Report on Form&nbsp;8-K filed with the SEC on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505925000011/leu-20250224.htm">February&nbsp;25, 2025</A>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">All reports and other documents we subsequently
file pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d)&nbsp;of the Exchange Act prior to the termination of this offering, including
all such documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness of the
registration statement, but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We will furnish without charge to you, on written
or oral request, a copy of any or all of the documents incorporated by reference, including exhibits to these documents. You should direct
any requests for documents in writing to: Centrus Energy Corp., 6901 Rockledge Drive, Suite&nbsp;800, Bethesda, MD 20817, tel: (301) 564-3200.
These documents are also available on the Investors section of our website, which is located at www.centrusenergy.com, or as described
under &ldquo;Where You Can Find Additional Information&rdquo; above. The reference to our website address does not constitute incorporation
by reference of the information contained on our website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">You should rely only on information contained
in, or incorporated by reference into, this prospectus supplement. We have not authorized anyone to provide you with information different
from that contained in this prospectus supplement or incorporated by reference in this prospectus supplement. We are not making offers
to sell the securities in any jurisdiction in which such an offer or solicitation is not authorized or in which the person making such
offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make such offer or solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2514263d1_424b5img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Centrus Energy Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>$200,000,000</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Preferred Stock</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Debt Securities</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrants</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Rights</B></P>

<P STYLE="font: 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, we may
offer and sell up to $200,000,000 in aggregate of the securities described in this prospectus separately or together in any combination,
in one or more classes or series, in amounts, at prices and on terms that we will determine at the time of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus provides
a general description of the securities we may offer. We may provide specific terms of securities to be offered in one or more supplements
to this prospectus. We may also provide a specific plan of distribution for any securities to be offered in a prospectus supplement.
Prospectus supplements may also add, update or change information in this prospectus. You should carefully read this prospectus and the
applicable prospectus supplement, together with any documents incorporated by reference herein, before you invest in our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is listed
on The NYSE American LLC, or the NYSE American, under the symbol &ldquo;LEU.&rdquo; On June&nbsp;27, 2023, the last reported sale price
of our common stock was $31.47 per share. The applicable prospectus supplement will contain information, where applicable, as to the
listing of any other securities covered by the prospectus supplement other than our common stock on the NYSE American or any other securities
exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Investing in any of our
securities involves a high degree of risk. Please read carefully the section entitled &ldquo;Risk Factors&rdquo; on page&nbsp;8 of this
prospectus, the &ldquo;Risk Factors&rdquo; section contained in the applicable prospectus supplement and the information included and
incorporated by reference in this prospectus.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this prospectus is ,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Page</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 95%; text-align: left"><A HREF="#a_001">About This Prospectus</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><A HREF="#a_001">1</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_002">Where You Can Find More Information</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_002">2</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_003">Information We Incorporate By Reference</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_003">3</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_004">Special Note Regarding Forward-Looking Statements</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_004">4</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_005">Centrus Energy Corp.</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_005">7</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_006">Risk Factors</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_006">8</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_007">Use Of Proceeds</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_007">9</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_008">Description Of Capital Stock</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_008">10</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_009">Description Of Debt Securities</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_009">12</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_010">Description Of Warrants</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_010">18</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_011">Description Of Rights</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_011">21</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_012">Description Of Units</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_012">22</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_013">Plan Of Distribution</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_013">23</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><A HREF="#a_014">Legal Matters</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_014">25</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_015">Experts</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><A HREF="#a_015">25</A></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_001"></A>About
This Prospectus</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is part of
a registration statement on Form&nbsp;S-3 that we filed with the Securities and Exchange Commission, or the SEC, using a &ldquo;shelf&rdquo;
registration or continuous offering process. Under this shelf registration process, we may, from time to time, sell any combination of
the securities described in this prospectus in one or more offerings up to a total aggregate offering price of $200,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus provides
a general description of the securities we may offer. We may provide specific terms of securities to be offered in one or more supplements
to this prospectus. We may also provide a specific plan of distribution for any securities to be offered in a prospectus supplement.
Prospectus supplements may also add, update or change information in this prospectus. If the information varies between this prospectus
and the accompanying prospectus supplement, you should rely on the information in the accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before purchasing any securities,
you should carefully read both this prospectus and any prospectus supplement, together with the additional information described under
the heading &ldquo;Information We Incorporate by Reference.&rdquo; You should rely only on the information contained or incorporated
by reference in this prospectus, any prospectus supplement and any free writing prospectus prepared by or on behalf of us or to which
we have referred you. Neither we nor any underwriters have authorized any other person to provide you with different information. If
anyone provides you with different or inconsistent information, you should not rely on it. We take no responsibility for, and can provide
no assurance as to the reliability of, any other information that others may give you. You should assume that the information contained
in this prospectus, any prospectus supplement or any free writing prospectus is accurate only as of the date on its respective cover,
and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, unless
we indicate otherwise. Our business, financial condition, results of operations and prospects may have changed since those dates. This
prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the
actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some
of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration
statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the heading &ldquo;Where
You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus and any applicable
prospectus supplement do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered
securities to which they relate. We are not making offers to sell common stock or any other securities described in this prospectus in
any jurisdiction in which an offer or solicitation is not authorized or in which we are not qualified to do so or to anyone to whom it
is unlawful to make an offer or solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise expressly
indicated or the context otherwise requires, we use the terms &ldquo;Centrus,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo;
 &ldquo;our&rdquo; or similar references to refer to Centrus Energy Corp. and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_002"></A>Where
You Can Find More Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have filed our registration
statement on Form&nbsp;S-3 with the SEC under the Securities Act of 1933, as amended, or the Securities Act. We also file annual, quarterly
and current reports, proxy statements and other information with the SEC. You may read and copy any document that we file with the SEC,
including the registration statement and the exhibits to the registration statement, at the SEC&rsquo;s Public Reference Room located
at 100 F Street, N.E., Washington D.C. 20549. You may obtain further information on the operation of the Public Reference Room by calling
the SEC at 1-800-SEC-0330. Our SEC filings are also available to the public at the SEC&rsquo;s web site at www.sec.gov. These documents
may also be accessed on our web site at www.centrusenergy.com. Information contained on our web site is not incorporated by reference
into this prospectus and you should not consider information contained on our web site to be part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus and any prospectus
supplement are part of a registration statement filed with the SEC and do not contain all of the information in the registration statement.
The full registration statement may be obtained from the SEC or us as indicated above. Forms of any indenture or other documents establishing
the terms of the offered securities are filed as exhibits to the registration statement or will be filed through an amendment to our
registration statement on Form&nbsp;S-3 or under cover of a Current Report on Form&nbsp;8-K and incorporated into this prospectus by
reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_003"></A>Information
We Incorporate By Reference</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The SEC allows us to &ldquo;incorporate
by reference&rdquo; into this prospectus the information we file with it, which means that we can disclose important information to you
by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus. Any statement
contained herein or in a document incorporated or deemed to be incorporated by reference into this document will be deemed to be modified
or superseded for purposes of the document to the extent that a statement contained in this document or any other subsequently filed
document that is deemed to be incorporated by reference into this document modifies or supersedes the statement. We incorporate by reference
in this prospectus the following information (other than, in each case, documents or information deemed to have been furnished and not
filed in accordance with SEC rules):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our
                                            <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505923000009/leu-20221231.htm">Annual
                                            Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2022 (filed with the
                                            SEC on February&nbsp;22, 2023)</A>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            information specifically incorporated by reference into our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505923000009/leu-20221231.htm">Annual
                                            Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2022</A> from our <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000110465923053429/tm231960d7_defr14a.htm">Definitive
                                            Proxy Statement on Schedule 14A (filed with the SEC on May&nbsp;1, 2023)</A>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our
                                            <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505923000015/leu-20230331.htm">Quarterly
                                            Report on Form&nbsp;10-Q for the fiscal quarter ended March&nbsp;31, 2023 (filed with the
                                            SEC on May&nbsp;9, 2023)</A>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our
                                            Current Reports on Form&nbsp;8-K filed with the SEC on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505923000011/leu-20230306.htm">March&nbsp;8,
                                            2023</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505923000017/leu-20230609.htm">June&nbsp;14,
                                            2023</A> and<A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505923000022/leu-20230620.htm">
                                            June 21, 2023</A>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">our
                                            Form<A HREF="https://www.sec.gov/Archives/edgar/data/1065059/000106505923000025/form8a-a_20230620.htm">&nbsp;8-A12B/A,
                                            filed with the SEC on June&nbsp;21 2023</A>; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            description of the securities of the Company contained in <A HREF="https://www.sec.gov/Archives/edgar/data/1065059/000106505923000009/exhibit_416xdescriptionofs.htm">Exhibit&nbsp;4.16</A>
                                            of our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2022 (filed with
                                            the SEC on February&nbsp;22, 2023).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We also incorporate by reference
each of the documents that we file with the SEC under Sections 13(a), 13(c), 14 or 15(d)&nbsp;of the Securities Exchange Act of 1934,
as amended, or the Exchange Act, on or after the date of this prospectus and prior to the termination of the offerings under this prospectus
and any prospectus supplement. These documents include periodic reports, such as Annual Reports on Form&nbsp;10-K, Quarterly Reports
on Form&nbsp;10-Q and Current Reports on Form&nbsp;8-K, as well as proxy statements. We will not, however, incorporate by reference in
this prospectus any documents or portions thereof that are not deemed &ldquo;filed&rdquo; with the SEC, including any information furnished
pursuant to Item 2.02 or Item 7.01 of our Current Reports on Form&nbsp;8-K after the date of this prospectus unless, and except to the
extent, specified in such Current Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We will provide to each
person, including any beneficial owner, to whom a prospectus (or a notice of registration in lieu thereof) is delivered a copy of any
of these filings (other than an exhibit to these filings, unless the exhibit is specifically incorporated by reference as an exhibit
to this prospectus) at no cost, upon a request to us by writing or telephoning us at the following address and telephone number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Centrus Energy Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">6901 Rockledge Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Suite&nbsp;800</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Bethesda, MD 20817</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(301) 564-3200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_004"></A>Special
Note Regarding Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus, including
the documents incorporated by reference herein, may contain or incorporate &ldquo;forward-looking statements&rdquo; within the meaning
of Section&nbsp;21E of the Securities Exchange Act of 1934 as amended, and the Private Securities Litigation Reform Act of 1995. In this
context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial
performance, and often contain words such as &ldquo;expects&rdquo;, &ldquo;anticipates&rdquo;, &ldquo;intends&rdquo;, &ldquo;plans&rdquo;,
 &ldquo;believes&rdquo;, &ldquo;will&rdquo;, &ldquo;should&rdquo;, &ldquo;could&rdquo;, &ldquo;would&rdquo; or &ldquo;may&rdquo; and other
words of similar meaning. These forward-looking statements are based on information available to us as of the date of this prospectus
and represent management&rsquo;s current views and assumptions with respect to future events and operational, economic and financial
performance. Forward-looking statements are not guarantees of future performance, events or results and involve known and unknown risks,
uncertainties and other factors, which may be beyond our control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For Centrus, particular risks
and uncertainties that could cause our actual future results to differ materially from those expressed in our forward-looking statements
include but are not limited to the following which are, and will be, exacerbated by any worsening of the global business and economic
environment as a result:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks related to the war in Ukraine factors</B>&nbsp;primarily
include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to the war in Ukraine and geopolitical conflicts and the imposition of sanctions
                                            or other measures by (i)&nbsp;the U.S. or foreign governments, (ii)&nbsp;organizations (including
                                            the United Nations, the EU or other international organizations), or (iii)&nbsp;entities
                                            (including private entities or persons), that could directly or indirectly impact our ability
                                            to obtain, deliver or sell LEU under the TENEX Supply Contract or make related payments or
                                            deliveries of natural uranium; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">risks
                                            related to the refusal of TENEX to deliver LEU to us if, among other reasons, TENEX is unable
                                            to receive payments, or to receive the return of natural uranium, as a result of any government,
                                            international or corporate actions or directions or other reasons.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks related to economic and industry factors</B>&nbsp;primarily
include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to whether or when government funding or demand for high assay low enriched uranium
                                            (&ldquo;HALEU&rdquo;) for government or commercial uses will materialize;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            and uncertainties regarding funding for continuation and deployment of the American Centrifuge
                                            technology;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to (i)&nbsp;our ability to perform and absorb costs under the HALEU Operation Contract,
                                            (ii)&nbsp;our ability to obtain contracts and funding to be able to continue operations and
                                            (iii)&nbsp;our ability to obtain and/or perform under other agreements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            that (i)&nbsp;we may not obtain the full benefit of the HALEU Operation Contract and may
                                            not be able or allowed to operate the HALEU enrichment facility to produce HALEU after the
                                            completion of the HALEU Operation Contract or (ii)&nbsp;the HALEU enrichment facility may
                                            not be available to us as a future source of supply;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our dependence on others, such as TENEX, under the TENEX Supply Contract, Orano
                                            under the Orano Supply Agreement and other suppliers (including transporters) who provide
                                            us the goods and services we need to conduct our business;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to natural and other disasters, including the continued impact of the March&nbsp;2011
                                            earthquake and tsunami in Japan on the nuclear industry and on our business, results of operations
                                            and prospects;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to financial difficulties experienced by customers or suppliers, including possible
                                            bankruptcies, insolvencies, or any other situation, event or occurrence that affect the ability
                                            of others to pay for our products or services in a timely manner or at all;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to pandemics, endemics, and other health crises;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the impact and potential extended duration of a supply/demand imbalance in the
                                            market for LEU;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our ability to sell or deliver the LEU we procure pursuant to our purchase obligations
                                            under our supply agreements and the impacts of sanctions or limitations on imports of such
                                            LEU, including those imposed under the RSA, international trade legislation and other international
                                            trade restrictions;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to existing or new trade barriers and to contract terms that limit our ability to
                                            procure LEU for, or deliver LEU to customers;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to pricing trends and demand in the uranium and enrichment markets and their impact
                                            on our profitability;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the movement and timing of customer orders;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our reliance on third-party suppliers and service providers to provide essential
                                            products and services to us;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the fact that we face significant competition from major producers who may be
                                            less cost sensitive or are wholly or partially government owned;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            that our ability to compete in foreign markets may be limited for various reasons;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the fact that our revenue is largely dependent on our largest customers; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our sales Order Book, including uncertainty concerning customer actions under
                                            current contracts and in future contracting due to market conditions, global events or other
                                            factors including our lack of current production capability.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks related to operational factors</B>&nbsp;primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to uncertainty regarding our ability to commercially deploy competitive enrichment
                                            technology;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the potential for demobilization or termination of our American Centrifuge work;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            that we will not be able to timely complete the work that we are obligated to perform; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our ability to perform fixed-price and cost-share contracts such as the HALEU
                                            Operation Contract, including the risk that costs that we must bear could be higher than
                                            expected.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks related to financial factors</B>&nbsp;primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our significant long-term liabilities, including material unfunded defined benefit
                                            pension plan obligations and postretirement health and life benefit obligations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            of revenue and operating results fluctuating significantly from quarter to quarter, and in
                                            some cases, year to year;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the impact of financial market conditions on our business, liquidity, prospects,
                                            pension assets and insurance facilities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the Company&rsquo;s capital concentration;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the value of our intangible assets related to the Order Book and customer relationships;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the limited trading markets in our securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to decisions made by our Class&nbsp;B stockholders regarding their investment in
                                            the Company based upon factors that are unrelated to the Company&rsquo;s performance;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            that a small number of holders of our Class&nbsp;A Common Stock (whose interests may not
                                            be aligned with other holders of our Class&nbsp;A Common Stock), may exert significant influence
                                            over the direction of the Company and may be motivated by interests that are not aligned
                                            with the Company&rsquo;s other Class&nbsp;A stockholders;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to (i)&nbsp;the use of our NOL carryforwards and NUBILs to offset future taxable
                                            income and the use of the Rights Agreement (as defined herein) to prevent an &ldquo;ownership
                                            change&rdquo; as defined in Section&nbsp;382 of the IRC and (ii)&nbsp;our ability to generate
                                            taxable income to utilize all or a portion of the NOLs prior to the expiration thereof and
                                            NUBILs; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">failures
                                            or security breaches of our information technology systems.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks related to general factors</B>&nbsp;primarily include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our ability to attract and retain key personnel;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to actions, including reviews, that may be taken by the U.S. government, the Russian
                                            government, or other governments that could affect our ability to perform under our contractual
                                            obligations or the ability of our sources of supply to perform under their contractual obligations
                                            to us;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to our ability to perform and receive timely payment under our agreements with the
                                            Department of Energy (&ldquo;DOE&rdquo;) or other government agencies, including risks and
                                            uncertainties related to the ongoing funding by the government and potential audits;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to changes or termination of our agreements with the U.S. government or other counterparties,
                                            or the exercise of contract remedies by such counterparties;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the competitive environment for our products and services;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to changes in the nuclear energy industry;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the competitive bidding process associated with obtaining contracts, including
                                            government contracts;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            that we will be unable to obtain new business opportunities or achieve market acceptance
                                            of our products and services or that products or services provided by others will render
                                            our products or services obsolete or noncompetitive; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to potential strategic transactions that could be difficult to implement, disrupt
                                            our business or change our business profile significantly.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risks related to legal and compliance factors</B>&nbsp;primarily
include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the outcome of legal proceedings and other contingencies (including lawsuits and
                                            government investigations or audits);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            related to the impact of government regulation and policies, including by the DOE and the
                                            U.S. NRC;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            of accidents during the transportation, handling, or processing of toxic hazardous or radioactive
                                            material that may pose a health risk to humans or animals, cause property or environmental
                                            damage, or result in precautionary evacuations, and lead to claims against the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">risks
                                            associated with claims and litigation arising from past activities at sites we currently
                                            operate or past activities at sites that we no longer operate, including the Paducah, Kentucky
                                            and Portsmouth, Ohio GDPs; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">other
                                            risks and uncertainties discussed in this and our other filings with the SEC.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For a more detailed discussion
of these risks and uncertainties and others that could cause actual results to differ materially from those contained in our forward-looking
statements, please see our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2022. Readers are cautioned not to place
undue reliance on these forward-looking statements, which apply only as of the date of this prospectus. These factors may not constitute
all factors that could cause actual results to differ from those discussed in any forward-looking statement. Accordingly, forward-looking
statements should not be relied upon as a predictor of actual results. Readers are urged to carefully review and consider the various
disclosures made in this prospectus and in our other filings with the SEC that attempt to advise interested parties of the risks and
factors that may affect our business. We do not undertake to update our forward-looking statements to reflect events or circumstances
that may arise after the date of this prospectus, except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_005"></A>Centrus
Energy Corp.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Centrus Energy Corp., a Delaware
corporation (&ldquo;Centrus&rdquo; or the &ldquo;Company&rdquo;), is a trusted supplier of nuclear fuel and services for the nuclear
power industry. References to &ldquo;Centrus&rdquo;, the &ldquo;Company&rdquo;, &ldquo;our&rdquo;, or &ldquo;we&rdquo; include Centrus
Energy Corp. and its wholly owned subsidiaries as well as the predecessor to Centrus, unless the context otherwise indicates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Centrus operates two business
segments: (a)&nbsp;low-enriched uranium (&ldquo;LEU&rdquo;), which supplies various components of nuclear fuel to commercial customers
from our global network of suppliers, and (b)&nbsp;Technical Solutions, which provides advanced engineering, design, and manufacturing
services to government and private sector customers and is deploying uranium enrichment and other capabilities necessary for production
of advanced nuclear fuel to power existing and next-generation reactors around the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our LEU segment provides
most of the Company&rsquo;s revenue and involves the sale of enriched uranium, the fissile component of nuclear fuel to customers, which
are primarily utilities that operate commercial nuclear power plants. The majority of these sales are for the enrichment component of
LEU, which is measured in separative work units (&ldquo;SWU&rdquo;). Centrus also sells natural uranium (the raw material needed to produce
LEU) and occasionally sells LEU with the natural uranium, uranium conversion, and SWU components combined into one sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">LEU is a critical component
in the production of nuclear fuel for reactors that produce electricity. We supply LEU and its components to both domestic and international
utilities for use in nuclear reactors worldwide. We provide LEU from multiple sources, including our inventory, medium and long-term
supply contracts, and spot purchases. As a long-term supplier of LEU to our customers, our objective is to provide value through the
reliability and diversity of our supply sources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Technical Solutions segment
is dedicated to the restoration of America&rsquo;s domestic uranium enrichment capability to play a critical role in meeting U.S. national
security and energy security requirements and advancing America&rsquo;s nonproliferation, energy, and climate objectives. Our Technical
Solutions segment also is focused on repairing broken and vulnerable supply chains, providing clean energy jobs, and supporting the communities
in which we operate. Our goal is to deliver major components of the next-generation nuclear fuels that will power the future of nuclear
energy as it provides reliable carbon-free power around the world.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At present, there are a number
of advanced reactors under development that would use high assay low-enriched uranium (&ldquo;HALEU&rdquo;) fuel. Under the HALEU Operation
Contract, Centrus is completing construction a cascade of sixteen AC100M centrifuges in Piketon, Ohio, for the DOE to demonstrate HALEU
production. Centrus expects to begin production of a small quantity of HALEU by the end of 2023 after receiving approval from the U.S.
Nuclear Regulatory Commission (&ldquo;NRC&rdquo;). The Company&rsquo;s goal is to complete the demonstration and scale up production
of HALEU, to meet the needs of new and existing reactors to support energy security as well as national security and other U.S. government
requirements for enriched uranium.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe our investments
in our enrichment technology and the HALEU demonstration will position the Company to meet the needs of government and commercial customers
in the future as they deploy advanced reactors and next generation fuels, and also offers potential cost synergies for a return to LEU
production.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our principal executive office
is located at 6901 Rockledge Drive, Suite&nbsp;800, Bethesda, Maryland 20817, and our telephone number is (301) 564-3200. Our website
is www.centrusenergy.com. However, the information located on, or accessible from, our website is not, and should not be deemed to be,
part of this prospectus, any accompanying prospectus supplement or any free writing prospectus or incorporated into any other filing
that we submit to the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_006"></A>Risk
Factors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investing in our securities
involves a high degree of risk. Before making an investment decision, you should carefully consider any risk factors set forth in the
applicable prospectus supplement and the documents incorporated by reference in this prospectus, including the factors discussed under
the heading &ldquo;Risk Factors&rdquo; in our most recent Annual Report on Form&nbsp;10-K and each subsequently filed Quarterly Report
on Form&nbsp;10-Q and any risk factors set forth in our other filings with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d)&nbsp;of
the Securities Exchange. See &ldquo;Where You Can Find More Information&rdquo; and &ldquo;Information We Incorporate By Reference.&rdquo;
Each of the risks described in these documents could materially and adversely affect our business, financial condition, results of operations
and prospects, and could result in a partial or complete loss of your investment. Additional risks and uncertainties not presently known
to us, or that we currently deem immaterial, may also adversely affect our business. In addition, past financial performance may not
be a reliable indicator of future performance and historical trends should not be used to anticipate results or trends in future periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_007"></A>Use
Of Proceeds</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will retain broad discretion
over the use of the net proceeds from the sale of the securities offered hereby. Unless otherwise specified in any prospectus supplement,
we currently intend to use the net proceeds from the sale of our securities offered under this prospectus for working capital and general
corporate purposes including, but not limited to, capital expenditures, working capital, repayment of indebtedness, potential acquisitions
and other business opportunities. Pending any specific application, we may initially invest funds in short-term marketable securities
or apply them to the reduction of indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_008"></A>Description
Of Capital Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The authorized capital stock
of Centrus Energy Corp. consists of (a)&nbsp;100,000,000 shares of common stock, par value $0.10 per share, of which 70,000,000 shares
are classified as Class&nbsp;A Common Stock, and 30,000,000 shares are classified as Class&nbsp;B Common Stock, and (b)&nbsp;20,000,000
shares of preferred stock, par value $1.00 per share, of which 2,000,000 shares have been designated Series&nbsp;A Participating Cumulative
Preferred Stock, and 0 shares of which have been designated Series&nbsp;B Senior Preferred Stock. The Class&nbsp;A Common Stock is registered
pursuant to Section&nbsp;12 of the Securities Exchange Act of 1934, as amended, and trades on the NYSE American platform under the symbol
 &ldquo;LEU.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description
of the terms of our securities is not complete and is qualified in its entirety by reference to the Company&rsquo;s Amended and Restated
Certificate of Incorporation (the &ldquo;Certificate of Incorporation&rdquo;), the Company&rsquo;s Third Amended and Restated Bylaws
(the &ldquo;Bylaws&rdquo;), and the Rights Agreement (as defined below), all of which are exhibits to our Annual Report on Form&nbsp;10-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Class&nbsp;A Common Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of Class&nbsp;A
Common Stock are entitled to one vote for each outstanding share of Class&nbsp;A Common Stock owned by that stockholder on every matter
properly submitted to the stockholders for their vote, except for any amendment for the Certificate of Incorporation that relates solely
to the terms of one or more outstanding series of Preferred Stock or Class&nbsp;B Common Stock. Generally, all matters to be voted on
by stockholders, other than the election of directors, must be approved by a majority in voting power of the stock represented and entitled
to vote. However, questions governed expressly by provisions of the Certificate of Incorporation, bylaws, applicable stock exchange rules&nbsp;or
applicable law require approval as set forth in the applicable governing document, stock exchange rule&nbsp;or law. The holders of Class&nbsp;B
Common Stock currently are entitled to elect up to one director, which right is subject to change based on certain holding requirements.
Otherwise, the directors are elected by a plurality of votes cast on the election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the rights of
the holders of any series of Preferred Stock outstanding at any time, the holders of Class&nbsp;A Common Stock and Class&nbsp;B Common
Stock will be entitled share ratably, based upon the number of shares held, in such dividends and other distributions of cash or any
other right or property as may be declared by the Board of Directors out of the assets or funds legally available for such dividends
or distributions, with sharing equally in such dividends or distributions. The Company is not permitted to pay dividends on the Common
Stock while any shares of Series&nbsp;B Preferred Stock are outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of any voluntary
or involuntary liquidation, dissolution or winding up of the Company&rsquo;s affairs, holders of Class&nbsp;A Common Stock and Class&nbsp;B
Common Stock would be entitled to share ratably, based upon the number of shares held, in assets that are legally available for distribution
to stockholders after payment of liabilities. If there is any preferred stock outstanding at such time, holders of the preferred stock
may be entitled to distribution and/or liquidation preferences. The Company currently has zero shares of Series&nbsp;B Preferred Stock
outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Certificate of Incorporation
does not provide for any conversion, sinking fund, redemption, preference, preemptive right, or right of subscription for the Class&nbsp;A
Common Stock. Issued and outstanding shares of Class&nbsp;B Common Stock convert into shares of Class&nbsp;A Common Stock upon transfer
to a party other than the current Class&nbsp;B stockholders and their respective affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Provisions of the Company&rsquo;s Certificate of Incorporation,
Bylaws and Delaware Law that May&nbsp;Have an Anti-Takeover Effect</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Certificate of Incorporation
and Bylaws.</I><B>&nbsp;</B>The Certificate of Incorporation and Bylaws provide that a special meeting of stockholders may be called
only by the Chairman, the President, the Board of Directors or a committee empowered by the Board of Directors to call a special meeting.
Stockholders are not permitted to call, or to require that the Board of Directors call, a special meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that levels
of foreign ownership of the Company&rsquo;s stock established by the Certificate of Incorporation are exceeded, the Board of Directors
has the right to take certain actions with respect to such ownership. These actions include requesting information from holders (or proposed
holders) of the Company&rsquo;s securities, refusing to permit the transfer of securities by such holders, suspending or limiting voting
rights of such holders, redeeming or exchanging shares of the Company&rsquo;s stock owned by such holders on terms set forth in the Certificate
of Incorporation, and taking other actions that deemed necessary or appropriate to ensure compliance with the foreign ownership restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Delaware Takeover Statute.<B>&nbsp;</B></I>The
Company is subject to Section&nbsp;203 of the Delaware General Corporation Law (the &ldquo;DGCL&rdquo;), which, subject to certain exceptions,
prohibits a Delaware corporation from engaging in any &ldquo;business combination&rdquo; (as defined below) with any &ldquo;interested
stockholder&rdquo; (as defined below) for a period of three years following the date that such stockholder became an interested stockholder,
unless: (i)&nbsp;prior to such date, the Board of Directors of the corporation approved either the business combination or the transaction
that resulted in the stockholder becoming an interested stockholder; (ii)&nbsp;on consummation of the transaction that resulted in the
stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation
outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding those shares
owned (x)&nbsp;by persons who are directors and also officers and (y)&nbsp;by employee stock plans in which employee participants do
not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer;
or (iii)&nbsp;on or subsequent to such date, the business combination is approved by the Board of Directors and authorized at an annual
or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting
stock that is not owned by the interested stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&nbsp;203 of the DGCL
defines &ldquo;business combination&rdquo; to include: (i)&nbsp;any merger or consolidation involving the corporation and the interested
stockholder; (ii)&nbsp;any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the
interested stockholder; (iii)&nbsp;subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation
of any stock of the corporation to the interested stockholder; (iv)&nbsp;any transaction involving the corporation that has the effect
of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder;
or (v)&nbsp;the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits
provided by or through the corporation. In general, Section&nbsp;203 of the DGCL defines an &ldquo;interested stockholder&rdquo; as any
entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated
with or controlling or controlled by such entity or person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Rights to Acquire Series&nbsp;A Participating Cumulative Preferred
Stock</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Centrus has adopted a Section&nbsp;382
stockholders rights plan and declared a dividend distribution of one right for each outstanding share of our common stock to stockholders
of record on April&nbsp;6, 2016. Each right entitles its holder, under the circumstances described below, to purchase from us one one-thousandth
of a share of our Series&nbsp;A Participating Cumulative Preferred Stock, par value $1.00 per share, at an exercise price of $18.00 per
right, subject to adjustment. The terms of the rights are set forth in a Section&nbsp;382 Rights Agreement between us, Computershare,&nbsp;Inc.
and Computershare Trust Company, N.A., as amended (the &ldquo;Rights Agreement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The rights plan is intended
to act as a deterrent to any person or group, together with its affiliates and associates, being or becoming the beneficial owner of
4.99% or more of common stock, with certain exceptions. The rights initially trade together with the common stock and are not exercisable.
In the absence of further action by the Board, the rights would generally become exercisable and allow a holder to acquire shares of
a new series of the Company&rsquo;s preferred stock if any person or group acquires 4.99% or more of the outstanding shares of the Company&rsquo;s
common stock, or if a person or group that already owns 4.99% or more of the Company&rsquo;s Class&nbsp;A Common Stock acquires additional
shares representing 0.5% or more of the outstanding shares of the Company&rsquo;s Class&nbsp;A Common Stock. The rights beneficially
owned by the acquirer would become null and void, resulting in significant dilution in the ownership interest of such acquirer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board may exempt any
acquisition of the Company&rsquo;s common stock from the provisions of the Rights Agreement if it determines that doing so would not
jeopardize or endanger the Company&rsquo;s use of its tax assets or is otherwise in the best interests of the Company. The Board also
has the ability to amend or terminate the Rights Agreement prior to a triggering event. Unless earlier terminated or extended in accordance
with the Rights Agreement, the rights issued under the Rights Agreement expire on June&nbsp;30, 2026.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_009"></A>Description
Of Debt Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description,
together with the additional information we include in any applicable prospectus supplement, summarizes certain general terms and provisions
of the debt securities that we may offer in one or more series under this prospectus. When we offer to sell a particular series of debt
securities, we will describe the specific terms of the series in a supplement to this prospectus. We will also indicate in the supplement
to what extent the general terms and provisions described in this prospectus apply to a particular series of debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue debt securities
either separately, or together with, or upon the conversion or exercise of or in exchange for, other securities described in this prospectus.
Debt securities may be our senior, senior subordinated or subordinated obligations and, unless otherwise specified in a supplement to
this prospectus, the debt securities will be our direct, unsecured obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will issue the debt securities
under the indenture that we will enter into with a national banking association or other eligible party, as trustee. The indenture will
be qualified under the Trust Indenture Act of 1939, as amended, or the Trust Indenture Act. We have filed the form of indenture as an
exhibit to the registration statement of which this prospectus is a part, and supplemental indentures and forms of debt securities containing
the terms of the debt securities being offered will be filed as exhibits to the registration statement of which this prospectus is a
part or will be incorporated by reference from reports that we file with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following summary of
material provisions of the debt securities and the indenture is subject to, and qualified in its entirety by reference to, all of the
provisions of the indenture applicable to a particular series of debt securities. The summary is not complete. The form of the indenture
has been filed as an exhibit to the registration statement and you should read the indenture for provisions that may be important to
you. We urge you to read the applicable prospectus supplements and any related free writing prospectuses related to the debt securities
that we may offer under this prospectus, as well as the complete indenture that contains the terms of the debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We can issue an unlimited
amount of debt securities under the indenture that may be in one or more series with the same or various maturities, at par, at a premium,
or at a discount. The terms of each series of debt securities will be established by or pursuant to a resolution of our board of directors
and set forth in an officer&rsquo;s certificate or a supplemental indenture. The particular terms of each series of debt securities will
be described in a prospectus supplement relating to such series (including any pricing supplement or term sheet), including the following
terms, if applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            title and ranking of the debt securities (including the terms of any subordination provisions);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            price or prices (expressed as a percentage of the principal amount) at which we will sell
                                            the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            aggregate principal amount of the debt securities being offered and any limit on the aggregate
                                            principal amount of such series of debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">whether
                                            any of our direct or indirect subsidiaries will guarantee the debt securities, including
                                            the terms of subordination, if any, of such guarantees;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            date or dates on which the principal of the securities of the series is payable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            interest rate, if any, and the method for calculating the interest rate;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            dates from which interest will accrue, the interest payment dates and the record dates for
                                            the interest payments;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            place or places where principal of, and any interest on, the debt securities will be payable
                                            (and the method of such payment), where the securities of such series may be surrendered
                                            for registration of transfer or exchange, and where notices and demands to us in respect
                                            of the debt securities may be delivered;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">any
                                            mandatory or optional redemption terms;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">any
                                            obligation we have to redeem or purchase the debt securities pursuant to any sinking fund
                                            or analogous provisions or at the option of a holder of debt securities and the period or
                                            periods within which, the price or prices at which and the terms and conditions upon which
                                            securities of the series shall be redeemed or purchased, in whole or in part, pursuant to
                                            such obligation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">any
                                            dates, if any, on which and the price or prices at which we will repurchase debt securities
                                            at the option of the holders of debt securities and other detailed terms and provisions of
                                            such repurchase obligations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            denominations in which the debt securities will be issued;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">whether
                                            the debt securities will be issued in the form of certificated debt securities or global
                                            debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            currency of denomination of the debt securities, which may be U.S. dollars or any foreign
                                            currency, and if such currency of denomination is a composite currency, the agency or organization,
                                            if any, responsible for overseeing such composite currency;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            designation of the currency, currencies or currency units in which payment of the principal
                                            of, and any interest on, the debt securities will be made;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">if
                                            payments of principal of, any interest on, the debt securities will be made in one or more
                                            currencies or currency units other than that or those in which the debt securities are denominated,
                                            the manner in which the exchange rate with respect to such payments will be determined;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            manner in which the amounts of payment of principal of, or any interest on, the debt securities
                                            will be determined, if these amounts may be determined by reference to an index based on
                                            a currency or currencies or by reference to a commodity, commodity index, stock exchange
                                            index or financial index;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">any
                                            provisions relating to any security provided for the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">any
                                            addition to, deletion of or change in the events of default described in this prospectus
                                            or in the indenture with respect to the debt securities and any change in the acceleration
                                            provisions described in this prospectus or in the indenture with respect to the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">any
                                            addition to, deletion of or change in the covenants described in this prospectus or in the
                                            indenture with respect to the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">any
                                            depositaries, interest rate calculation agents, exchange rate calculation agents or other
                                            agents appointed with respect to the debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            provisions, if any, relating to conversion or exchange of any series of debt securities,
                                            including if applicable, the conversion or exchange price and period, the securities or other
                                            property into which the debt securities will be convertible, provisions as to whether conversion
                                            or exchange will be mandatory, at the option of the holders thereof or at our option, the
                                            events requiring an adjustment of the conversion price or exchange price and provisions affecting
                                            conversion or exchange if such series of debt securities are redeemed; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">any
                                            other terms of the series of debt securities that may supplement, modify or delete any provision
                                            of the indenture as it applies to that series, including any terms that may be required under
                                            applicable law or regulations or advisable in connection with the marketing of the debt securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue debt securities
that provide for an amount less than their stated principal amount to be due and payable upon maturity or a declaration of acceleration
of their maturity following an event of default pursuant to the terms of the indenture. We will provide you with information on the federal
income tax considerations and other special considerations applicable to any of these debt securities in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we denominate the purchase
price of any of the debt securities in a foreign currency or currencies or a foreign currency unit or units, or if the principal of and
any premium and interest on any series of debt securities is payable in a foreign currency or currencies or a foreign currency unit or
units, we will provide you with information on the restrictions, elections, general tax considerations, specific terms and other information
with respect to that issue of debt securities and such foreign currency or currencies or foreign currency unit or units in the applicable
prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Transfer and Exchange</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each debt security will be
represented by either one or more global securities registered in the name of The Depository Trust Company, or the depositary, or a nominee
of the depositary (we will refer to any such debt security as a &ldquo;global debt security&rdquo;), or a certificate issued in definitive
registered form (we will refer to any debt security represented by a certificate as a &ldquo;certificated debt security&rdquo;) as set
forth in the applicable prospectus supplement. Except as set forth below, global debt securities will not be issuable in certificated
form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Certificated Debt Securities</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may transfer or exchange
certificated debt securities at any office we maintain for this purpose in accordance with the terms of the indenture. No service charge
will be made for any transfer or exchange of certificated debt securities, but we may require payment of a sum sufficient to cover any
tax or other governmental charge payable in connection with a transfer or exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may effect the transfer
of certificated debt securities and the right to receive the principal of, premium and interest on certificated debt securities only
by surrendering the certificate representing those certificated debt securities and either reissuance by us or the trustee of the certificate
to the new holder or the issuance by us or the trustee of a new certificate to the new holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Global Debt Securities and Book-Entry System</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each global debt security
will be deposited with, or on behalf of, the depositary, and registered in the name of the depositary or a nominee of the depositary.
Beneficial interests in global debt securities will not be issuable in certificated form unless (i)&nbsp;the depositary has notified
us that it is unwilling or unable to continue as depositary for such global debt security or has ceased to be qualified to act as such
as required by the indenture and we fail to appoint a successor depositary within 90 days of such event, (ii)&nbsp;we determine, in our
sole discretion, not to have such securities represented by one or more global securities or (iii)&nbsp;any other circumstances shall
exist, in addition to or in lieu of those described above, as may be described in the applicable prospectus supplement. Unless and until
a global debt security is exchanged for certificated debt securities under the limited circumstances described in the previous sentence,
a global debt security may not be transferred except as a whole by the depositary to its nominee or by the nominee to the depositary,
or by the depositary or its nominee to a successor depositary or to a nominee of the successor depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Covenants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will set forth in the
applicable prospectus supplement any restrictive covenants applicable to any issue of debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>No Protection In the Event of a Change of Control</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless we state otherwise
in the applicable prospectus supplement, the debt securities will not contain any provisions which may afford holders of the debt securities
protection in the event we have a change in control or in the event of a highly leveraged transaction (whether or not such transaction
results in a change in control) which could adversely affect holders of debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Consolidation, Merger and Sale of Assets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Centrus may not consolidate
with or merge with or into, or convey, transfer or lease all or substantially all of its assets to any person (a &ldquo;successor person&rdquo;)
unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">Centrus
                                            is the surviving corporation or the successor person (if other than Centrus) is a corporation
                                            organized and validly existing under the laws of any U.S. domestic jurisdiction and expressly
                                            assumes Centrus&rsquo;s obligations on the debt securities and under the indenture; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">immediately
                                            after giving effect to the transaction, no default or event of default, shall have occurred
                                            and be continuing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the above,
any of Centrus&rsquo;s subsidiaries may consolidate with, merge into or transfer all or part of its properties to Centrus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Events of Default</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I>Event of Default</I>&rdquo;
means with respect to any series of debt securities, any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">default
                                            in the payment of any interest upon any debt security of that series when it becomes due
                                            and payable, and continuance of such default for a period of 30 days (unless the entire amount
                                            of the payment is deposited by us with the trustee or with a paying agent prior to the expiration
                                            of the 30-day period);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">default
                                            in the payment of principal of any security of that series at its maturity;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">default
                                            in the performance or breach of any covenant by us in the indenture (other than defaults
                                            described above or defaults relating to a covenant that has been included in the indenture
                                            solely for the benefit of a series of debt securities other than that series), which default
                                            continues uncured for a period of 60 days after we receive written notice from the trustee,
                                            or we and the trustee receive written notice from the holders of not less than 25% in principal
                                            amount of the outstanding debt securities of that series as provided in the indenture;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">certain
                                            voluntary or involuntary events of bankruptcy, insolvency or reorganization of Centrus; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">any
                                            other event of default provided with respect to a series of debt securities, including any
                                            events of default relating to guarantors, if any, or subsidiaries that is described in the
                                            applicable prospectus supplement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No event of default with
respect to a particular series of debt securities (except as to certain events of bankruptcy, insolvency or reorganization) necessarily
constitutes an event of default with respect to any other series of debt securities. The occurrence of certain events of default or an
acceleration under the indenture may constitute an event of default under certain indebtedness of ours or our subsidiaries outstanding
from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an event of default with
respect to any series of debt securities at the time outstanding occurs and is continuing (other than an event of default resulting from
certain events of bankruptcy, insolvency or reorganization), then the trustee or the holders of not less than 25% in principal amount
of the outstanding debt securities of that series may, by a notice in writing to us (and to the trustee if given by the holders), declare
to be due and payable immediately the principal of (or, if the debt securities of that series are discount securities, that portion of
the principal amount as may be specified in the terms of that series) and accrued and unpaid interest, if any, on all debt securities
of that series. In the case of an event of default resulting from certain events of bankruptcy, insolvency or reorganization, the principal
amount (or such specified amount) of and accrued and unpaid interest, if any, on all outstanding debt securities will become and be immediately
due and payable without any declaration or other act on the part of the trustee or any holder of outstanding debt securities. At any
time after a declaration of acceleration with respect to debt securities of any series has been made, but before a judgment or decree
for payment of the money due has been obtained by the trustee, the holders of a majority in principal amount of the outstanding debt
securities of that series, by written notice to us and the trustee, may rescind and annul such declaration of acceleration and its consequences
if all events of default, other than the non-payment of accelerated principal and interest, if any, with respect to debt securities of
that series, have been cured or waived as provided in the indenture. We refer you to the prospectus supplement relating to any series
of debt securities that are discount securities for the particular provisions relating to acceleration of a portion of the principal
amount of such discount securities upon the occurrence of an event of default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The indenture provides that
the trustee will be under no obligation to perform any duty or exercise any of its rights or powers under the indenture unless the trustee
receives indemnity satisfactory to it against any cost, liability or expense which might be incurred by it in performing such duty or
exercising such right of power. Subject to certain rights of the trustee, the holders of a majority in principal amount of the outstanding
debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available
to the trustee or exercising any trust or power conferred on the trustee with respect to the debt securities of that series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No holder of any debt security
of any series will have any right to institute any proceeding, judicial or otherwise, with respect to the indenture or for the appointment
of a receiver or trustee, or for any remedy under the indenture, unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">that holder has previously given to the trustee
written notice of a continuing event of default with respect to debt securities of that series;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            holders of not less than 25% in principal amount of the outstanding debt securities of that
                                            series have made written request to the trustee to institute the proceedings in respect of
                                            such event of default in its own name as trustee under the indenture;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">such
                                            holder or holders have offered to the trustee indemnity or security satisfactory to the trustee
                                            against the costs, expenses and liabilities which might be incurred by the trustee in compliance
                                            with such request;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            trustee has failed to institute any such proceeding for 60 days after its receipt of such
                                            notice, request and offer of indemnity; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">no
                                            direction inconsistent with such written request has been given to the trustee during such
                                            60-day period by holders of a majority in principal amount of the outstanding debt securities
                                            of that series.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding any other
provision in the indenture, the holder of any debt security will have an absolute and unconditional right to receive payment of the principal
of, and any interest on, that debt security on or after the due dates expressed in that debt security (or, in the case of redemption,
on the redemption date) and to institute suit for the enforcement of any such payment and such rights shall not be impaired without the
consent of such holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The indenture requires us,
within 120 days after the end of our fiscal year, to furnish to the trustee a statement as to compliance with the indenture from our
principal executive officer, principal financial officer or principal accounting officer. If a default or event of default occurs and
is continuing with respect to the debt securities of any series and if it is actually known to a responsible officer of the trustee,
the trustee shall mail to each holder of the debt securities of that series notice of a default or event of default within 60 days after
it occurs or, if later, after a responsible officer of the trustee has knowledge of such default or event of default. The indenture provides
that the trustee may withhold notice to the holders of debt securities of any series of any default or event of default (except in payment
on any debt securities of that series) with respect to debt securities of that series if the trustee determines in good faith that withholding
notice is in the interest of the holders of those debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Modification and Waiver</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We and the trustee may modify
and amend or supplement the indenture or the debt securities of one or more series without the consent of any holder of any debt security:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">to
                                            add guarantees with respect to debt securities of a series or secure debt securities of a
                                            series;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">to
                                            surrender any of our rights or powers under the indenture;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">to
                                            add covenants or events of default for the benefit of the holders of any series of debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">to
                                            comply with the applicable procedures of the applicable depositary;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">to
                                            cure any ambiguity, defect or inconsistency;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">to
                                            comply with covenants in the indenture described above under the heading &ldquo;Consolidation,
                                            Merger and Sale of Assets&rdquo;;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">to
                                            provide for uncertificated securities in addition to or in place of certificated securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">to
                                            make any change that does not materially adversely affect the rights of any holder of debt
                                            securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">to
                                            provide for the issuance of and establish the form and terms and conditions of debt securities
                                            of any series as permitted by the indenture;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">to
                                            effect the appointment of a successor trustee with respect to the debt securities of any
                                            series and to add to or change any of the provisions of the indenture to provide for or facilitate
                                            administration by more than one trustee;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">to
                                            comply with requirements of the SEC in order to effect or maintain the qualification of the
                                            indenture under the Trust Indenture Act; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">for
                                            certain other reasons set forth in any prospectus supplement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may also modify and amend
the indenture with the consent of the holders of at least a majority in principal amount of the outstanding debt securities of each series
affected by the modifications or amendments. We may not make any modification or amendment without the consent of the holders of each
affected debt security then-outstanding if that amendment will:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">reduce
                                            the principal amount of debt securities whose holders must consent to an amendment, supplement
                                            or waiver;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">reduce
                                            the rate of or extend the time for payment of interest (including default interest) on any
                                            debt security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">reduce
                                            the principal of, or change the fixed maturity of, any debt security or reduce the amount
                                            of, or postpone the date fixed for, the payment of any sinking fund or analogous obligation
                                            with respect to any series of debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">reduce
                                            the principal amount of discount securities payable upon acceleration of maturity;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">waive
                                            a default in the payment of the principal of, or interest, if any, on any debt security (except
                                            a rescission of acceleration of the debt securities of any series by the holders of at least
                                            a majority in principal amount of the then-outstanding debt securities of that series and
                                            a waiver of the payment default that resulted from such acceleration);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">make
                                            the principal of, or any interest on, any debt security payable in currency other than that
                                            stated in the debt security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">make
                                            any change to certain provisions of the indenture relating to, among other things, the right
                                            of holders of debt securities to receive payment of the principal of, and any interest on,
                                            those debt securities and to institute suit for the enforcement of any such payment;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">make
                                            any change to certain provisions of the indenture relating to waivers or amendments; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">waive
                                            a redemption payment with respect to any debt security, provided that such redemption is
                                            made at our option.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except for certain specified
provisions, the holders of at least a majority in principal amount of the outstanding debt securities of any series may, on behalf of
the holders of all debt securities of that series, by written notice to the trustee, waive our compliance with provisions of the indenture
or the debt securities with respect to such series. The holders of a majority in principal amount of the outstanding debt securities
of any series may, on behalf of the holders of all the debt securities of such series, waive any past default under the indenture with
respect to that series and its consequences, except a default in the payment of the principal of, or any interest on, any debt security
of that series; provided, however, that the holders of a majority in principal amount of the outstanding debt securities of any series
may rescind an acceleration and its consequences, including any related payment default that resulted from the acceleration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Defeasance of Debt Securities and Certain Covenants in Certain
Circumstances</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Legal Defeasance</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The indenture provides that,
unless otherwise provided by the terms of the applicable series of debt securities, we may be discharged from any and all obligations
in respect of the debt securities of any series (subject to certain exceptions). We will be so discharged upon the deposit with the trustee,
in trust, of money and/or U.S. government obligations or, in the case of debt securities denominated in a single currency other than
U.S. dollars, government obligations of the government that issued or caused to be issued such currency, that, through the payment of
interest and principal in accordance with their terms, will provide money in an amount sufficient in the opinion of a nationally recognized
firm of independent public accountants or investment bank to pay and discharge each installment of principal and interest, if any, on
and any mandatory sinking fund payments in respect of the debt securities of that series on the stated maturity of those payments in
accordance with the terms of the indenture and those debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This discharge may occur
only if, among other things, we have delivered to the trustee an opinion of counsel stating that we have received from, or there has
been published by, the United States Internal Revenue Service a ruling or, since the date of execution of the indenture, there has been
a change in the applicable United States federal income tax law, in either case to the effect that, and based thereon such opinion shall
confirm that, the holders of the debt securities of that series will not recognize income, gain or loss for United States federal income
tax purposes as a result of the deposit, defeasance and discharge and will be subject to United States federal income tax on the same
amounts and in the same manner and at the same times as would have been the case if the deposit, defeasance and discharge had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Defeasance of Certain Covenants</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The indenture provides that,
unless otherwise provided by the terms of the applicable series of debt securities, upon compliance with certain conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">we
                                            may omit to comply with the covenant described under the heading &ldquo;Consolidation, Merger
                                            and Sale of Assets&rdquo; and certain other covenants set forth in the indenture, as well
                                            as any additional covenants which may be set forth in the applicable prospectus supplement;
                                            and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">any
                                            omission to comply with those covenants will not constitute a default or an event of default
                                            with respect to the debt securities of that series (&ldquo;covenant defeasance&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The conditions include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">depositing
                                            with the trustee money and/or U.S. government obligations or, in the case of debt securities
                                            denominated in a single currency other than U.S. dollars, government obligations of the government
                                            that issued or caused to be issued such currency, that, through the payment of interest and
                                            principal in</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">accordance
                                            with their terms, will provide money in an amount sufficient in the opinion of a nationally
                                            recognized firm of independent public accountants or investment bank to pay and discharge
                                            each installment of principal of, and interest, if any, on and any mandatory sinking fund
                                            payments in respect of the debt securities of that series on the stated maturity of those
                                            payments in accordance with the terms of the indenture and those debt securities; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">delivering
                                            to the trustee an opinion of counsel to the effect that the holders of the debt securities
                                            of that series will not recognize income, gain or loss for United States federal income tax
                                            purposes as a result of the deposit and related covenant defeasance and will be subject to
                                            United States federal income tax on the same amounts and in the same manner and at the same
                                            times as would have been the case if the deposit and related covenant defeasance had not
                                            occurred.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Governing Law</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The indenture and the debt
securities, including any claim or controversy arising out of or relating to the indenture or the securities, will be governed by the
laws of the State of New York (without regard to the conflicts of laws provisions thereof other than Section&nbsp;5-1401 of the General
Obligations Law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_010"></A>Description
Of Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description,
together with the additional information we include in any applicable prospectus supplement, summarizes the material terms and provisions
of the warrants that we may offer under this prospectus, which consist of warrants to purchase shares of common stock, preferred stock
and/or debt securities in one or more series. Warrants may be offered independently or together with shares of common stock, preferred
stock and/or debt securities offered by any prospectus supplement and may be attached to or separate from those securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While the terms we have summarized
below will generally apply to any future warrants we may offer under this prospectus, we will describe the particular terms of any warrants
that we may offer in more detail in the applicable prospectus supplement. The specific terms of any warrants may differ from the description
provided below as a result of negotiations with third parties in connection with the issuance of those warrants, as well as for other
reasons. Because the terms of any warrants we offer under a prospectus supplement may differ from the terms we describe below, you should
rely solely on information in the applicable prospectus supplement if that summary is different from the summary in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will issue the warrants
under a warrant agreement, which we will enter into with a warrant agent to be selected by us. We use the term &ldquo;warrant agreement&rdquo;
to refer to any of these warrant agreements. We use the term &ldquo;warrant agent&rdquo; to refer to the warrant agent under any of these
warrant agreements. The warrant agent will act solely as an agent of ours in connection with the warrants and will not act as an agent
for the holders or beneficial owners of the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will incorporate by reference
into the registration statement of which this prospectus is a part the form of warrant agreement, including a form of warrant certificate,
that describes the terms of the series of warrants we are offering before the issuance of the related series of warrants. The following
summaries of material provisions of the warrants and the warrant agreements are subject to, and qualified in their entirety by reference
to, all the provisions of the warrant agreement applicable to a particular series of warrants. We urge you to read any applicable prospectus
supplement related to the warrants that we sell under this prospectus, as well as the complete warrant agreement that contain the terms
of the warrants and defines your rights as a warrant holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will describe in the applicable
prospectus supplement the terms relating to a series of warrants. If warrants for the purchase of debt securities are offered, the prospectus
supplement will describe the following terms, to the extent applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            offering price and the aggregate number of warrants offered;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            currencies in which the warrants are being offered;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            designation, aggregate principal amount, currencies, denominations and terms of the series
                                            of debt securities that can be purchased if a holder exercises a warrant;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            designation and terms of any series of debt securities with which the warrants are being
                                            offered and the number of warrants offered with each such debt security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            date on and after which the holder of the warrants can transfer them separately from the
                                            related series of debt securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            terms of any rights to redeem or call the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            date on which the right to exercise the warrants begins and the date on which that right
                                            expires;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">federal
                                            income tax consequences of holding or exercising the warrants; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">any
                                            other specific terms, preferences, rights or limitations of, or restrictions on, the warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Warrants for the purchase
of debt securities will be in registered form only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If warrants for the purchase
of shares of common stock or preferred stock are offered, the prospectus supplement will describe the following terms, to the extent
applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            offering price and the aggregate number of warrants offered;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            total number of shares that can be purchased if a holder of the warrants exercises them;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            number of warrants being offered with each share of common stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            date on and after which the holder of the warrants can transfer them separately from the
                                            related shares of common stock or preferred stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            number of shares of common stock or preferred stock that can be purchased if a holder exercises
                                            the warrant and the price at which those shares may be purchased upon exercise, including,
                                            if applicable, any provisions for changes to or adjustments in the exercise price and in
                                            the securities or other property receivable upon exercise;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            terms of any rights to redeem or call, or accelerate the expiration of, the warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            date on which the right to exercise the warrants begins and the date on which that right
                                            expires;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">federal
                                            income tax consequences of holding or exercising the warrants; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">any
                                            other specific terms, preferences, rights or limitations of, or restrictions on, the warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Warrants for the purchase
of shares of common stock or preferred stock will be in registered form only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A holder of warrant certificates
may exchange them for new certificates of different denominations, present them for registration of transfer and exercise them at the
corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement. Until any warrants
to purchase debt securities are exercised, the holder of the warrants will not have any of the rights of holders of the debt securities
that can be purchased upon exercise, including any rights to receive payments of principal, premium or interest on the underlying debt
securities or to enforce covenants in the applicable indenture. Until any warrants to purchase shares of common stock or preferred stock
are exercised, holders of the warrants will not have any rights of holders of the underlying shares of common stock or preferred stock,
including any rights to receive dividends or to exercise any voting rights, except to the extent set forth under &ldquo;Warrant Adjustments&rdquo;
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exercise of Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each holder of a warrant
is entitled to purchase the principal amount of debt securities or number of shares of common stock or preferred stock, as the case may
be, at the exercise price described in the applicable prospectus supplement. After the close of business on the day when the right to
exercise terminates (or a later date if we extend the time for exercise), unexercised warrants will become void.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A holder of warrants may
exercise them by following the general procedure outlined below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">deliver
                                            to the warrant agent the payment required by the applicable prospectus supplement to purchase
                                            the underlying security;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">properly
                                            complete and sign the reverse side of the warrant certificate representing the warrants;
                                            and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">deliver
                                            the warrant certificate representing the warrants to the warrant agent within five business
                                            days of the warrant agent receiving payment of the exercise price.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you comply with the procedures
described above, your warrants will be considered to have been exercised when the warrant agent receives payment of the exercise price,
subject to the transfer books for the securities issuable upon exercise of the warrant not being closed on such date. After you have
completed those procedures and subject to the foregoing, we will, as soon as practicable, issue and deliver to you the debt securities
or shares of common stock or preferred stock that you purchased upon exercise. If you exercise fewer than all of the warrants represented
by a warrant certificate, a new warrant certificate will be issued to you for the unexercised amount of warrants. Holders of warrants
will be required to pay any tax or governmental charge that may be imposed in connection with transferring the underlying securities
in connection with the exercise of the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Amendments and Supplements to the Warrant Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may amend or supplement
a warrant agreement without the consent of the holders of the applicable warrants to cure ambiguities in the warrant agreement, to cure
or correct a defective provision in the warrant agreement, or to provide for other matters under the warrant agreement that we and the
warrant agent deem necessary or desirable, so long as, in each case, such amendments or supplements do not materially adversely affect
the interests of the holders of the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Warrant Adjustments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the applicable prospectus
supplement states otherwise, the exercise price of, and the number of securities covered by, a warrant for shares of common stock or
preferred stock will be adjusted proportionately if we subdivide or combine our common stock or preferred stock, as applicable. In addition,
unless the prospectus supplement states otherwise, if we, without payment:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">issue
                                            shares of common stock or preferred stock or other securities convertible into or exchangeable
                                            for common stock or preferred stock, or any rights to subscribe for, purchase or otherwise
                                            acquire any of the foregoing, as a dividend or distribution to all or substantially all holders
                                            of our common stock or preferred stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">pay
                                            any cash to all or substantially all holders of our common stock or preferred stock, other
                                            than a cash dividend paid out of our current or retained earnings;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">issue
                                            any evidence of our indebtedness or rights to subscribe for or purchase our indebtedness
                                            to all or substantially all holders of our common stock or preferred stock; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">issue
                                            common stock, preferred stock or additional shares or other securities or property to all
                                            or substantially all holders of our common stock or preferred stock by way of spinoff, split-up,
                                            reclassification, combination of shares or similar corporate rearrangement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">then the holders of common stock warrants or
preferred stock warrants will be entitled to receive upon exercise of the warrants, in addition to the securities otherwise receivable
upon exercise of the warrants and without paying any additional consideration, the amount of shares and other securities and property
such holders would have been entitled to receive had they held the common stock or preferred stock issuable under the warrants on the
dates on which holders of those securities received or became entitled to receive such additional shares and other securities and property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as stated above, the
exercise price and number of securities covered by a warrant for shares of common stock or preferred stock, and the amounts of other
securities or property to be received, if any, upon exercise of those warrants, will not be adjusted or provided for if we issue those
securities or any securities convertible into or exchangeable for those securities, or securities carrying the right to purchase those
securities or securities convertible into or exchangeable for those securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of common stock warrants
or preferred stock warrants may have additional rights under the following circumstances:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">certain
                                            reclassifications, capital reorganizations or changes of the common stock or preferred stock;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">certain
                                            share exchanges, mergers, or similar transactions involving us that result in changes of
                                            the common stock or preferred stock; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">certain
                                            sales or dispositions to another entity of all or substantially all of our property and assets.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If one of the above transactions
occurs and holders of our common stock or preferred stock are entitled to receive shares, securities or other property with respect to
or in exchange for their securities, the holders of the common stock warrants or preferred stock warrants then-outstanding, as applicable,
will be entitled to receive upon exercise of their warrants the kind and amount of shares and other securities or property that they
would have received upon the applicable transaction if they had exercised their warrants immediately before the transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_011"></A>Description
Of Rights</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following description,
together with the additional information we include in any applicable prospectus supplement, summarizes the general features of the rights
that we may offer under this prospectus. We may issue rights to our stockholders to purchase shares of our common stock and/or any of
the other securities offered hereby. Each series of rights will be issued under a separate rights agreement to be entered into between
us and a bank or trust company, as rights agent. When we issue rights, we will provide the specific terms of the rights and the applicable
rights agreement in a prospectus supplement. Because the terms of any rights we offer under a prospectus supplement may differ from the
terms we describe below, you should rely solely on information in the applicable prospectus supplement if that summary is different from
the summary in this prospectus. We will incorporate by reference into the registration statement of which this prospectus is a part the
form of rights agreement that describes the terms of the series of rights we are offering before the issuance of the related series of
rights. The applicable prospectus supplement relating to any rights will describe the terms of the offered rights, including, where applicable,
the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            date for determining the persons entitled to participate in the rights distribution;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            exercise price for the rights;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            aggregate number or amount of underlying securities purchasable upon exercise of the rights;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            number of rights issued to each stockholder and the number of rights outstanding, if any;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            extent to which the rights are transferable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            date on which the right to exercise the rights will commence and the date on which the right
                                            will expire;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            extent to which the rights include an over-subscription privilege with respect to unsubscribed
                                            securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">anti-dilution
                                            provisions of the rights, if any; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">any
                                            other terms of the rights, including terms, procedures and limitations relating to the distribution,
                                            exchange and exercise of the rights.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders may exercise rights
as described in the applicable prospectus supplement. Upon receipt of payment and the rights certificate properly completed and duly
executed at the corporate trust office of the rights agent or any other office indicated in the prospectus supplement, we will, as soon
as practicable, forward the securities purchasable upon exercise of the rights. If less than all of the rights issued in any rights offering
are exercised, we may offer any unsubscribed securities directly to persons other than stockholders, to or through agents, underwriters
or dealers or through a combination of such methods, including pursuant to standby underwriting arrangements, as described in the applicable
prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_012"></A>Description
Of Units</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue units comprising
two or more securities described in this prospectus in any combination. For example, we might issue units consisting of a combination
of debt securities and warrants to purchase common stock. The following description sets forth certain general terms and provisions of
the units that we may offer pursuant to this prospectus. The particular terms of the units and the extent, if any, to which the general
terms and provisions may apply to the units so offered will be described in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each unit will be issued
so that the holder of the unit also is the holder of each security included in the unit. Thus, the unit will have the rights and obligations
of a holder of each included security. Units will be issued pursuant to the terms of a unit agreement, which may provide that the securities
included in the unit may not be held or transferred separately at any time or at any time before a specified date. A copy of the forms
of the unit agreement and the unit certificate relating to any particular issue of units will be filed with the SEC each time we issue
units, and you should read those documents for provisions that may be important to you. For more information on how you can obtain copies
of the forms of the unit agreement and the related unit certificate, see &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The prospectus supplement
relating to any particular issuance of units will describe the terms of those units, including, to the extent applicable, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">the
                                            designation and terms of the units and the securities comprising the units, including whether
                                            and under what circumstances those securities may be held or transferred separately;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">any
                                            provision for the issuance, payment, settlement, transfer or exchange of the units or of
                                            the securities comprising the units; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">whether
                                            the units will be issued in fully registered or global form.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_013"></A>Plan
Of Distribution</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may sell the securities
from time to time, by a variety of methods, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">on
                                            any national securities exchange or quotation service on which our securities may be listed
                                            at the time of sale, including the NYSE American;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">in
                                            the over-the-counter market;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">in
                                            transactions otherwise than on such exchange or in the over-the-counter market, which may
                                            include privately negotiated transactions and sales directly to one or more purchasers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">through
                                            ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">through
                                            purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">through
                                            underwriters, broker-dealers, agents, in privately negotiated transactions, or any combination
                                            of these methods;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">through
                                            short sales;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">through
                                            the writing or settlement of options or other hedging transactions, whether through an options
                                            exchange or otherwise;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">a
                                            combination of any of these methods; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">by
                                            any other method permitted pursuant to applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The securities may be distributed
from time to time in one or more transactions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">at
                                            a fixed price or prices, which may be changed;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">at
                                            market prices prevailing at the time of sale;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">at
                                            prices related to such prevailing market prices; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify">at
                                            negotiated prices.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Offers to purchase the securities
being offered by this prospectus may be solicited directly. Agents may also be designated to solicit offers to purchase the securities
from time to time. Any agent involved in the offer or sale of our securities will be identified in a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a dealer is utilized in
the sale of the securities being offered by this prospectus, the securities will be sold to the dealer, as principal. The dealer may
then resell the securities to the public at varying prices to be determined by the dealer at the time of resale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an underwriter is utilized
in the sale of the securities being offered by this prospectus, an underwriting agreement will be executed with the underwriter at the
time of sale and the name of any underwriter will be provided in the prospectus supplement that the underwriter will use to make resales
of the securities to the public. In connection with the sale of the securities, we, or the purchasers of securities for whom the underwriter
may act as agent, may compensate the underwriter in the form of underwriting discounts or commissions. The underwriter may sell the securities
to or through dealers, and those dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters
and/or commissions from the purchasers for which they may act as agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise indicated
in a prospectus supplement, an agent will be acting on a best efforts basis and a dealer will purchase securities as a principal, and
may then resell the securities at varying prices to be determined by the dealer. Any compensation paid to underwriters, dealers or agents
in connection with the offering of the securities, and any discounts, concessions or commissions allowed by underwriters to participating
dealers will be provided in the applicable prospectus supplement. Underwriters, dealers and agents participating in the distribution
of the securities may be deemed to be underwriters within the meaning of the Securities Act, and any discounts and commissions received
by them and any profit realized by them on resale of the securities may be deemed to be underwriting discounts and commissions. In compliance
with the guidelines of the Financial Industry Regulatory Authority,&nbsp;Inc., or FINRA, the maximum amount of underwriting compensation,
including underwriting discounts and commissions, to be paid in connection with any offering of securities pursuant to this prospectus
may not exceed 8% of the aggregate principal amount of securities offered. We may enter into agreements to indemnify underwriters, dealers
and agents against civil liabilities, including liabilities under the Securities Act, or to contribute to payments they may be required
to make in respect thereof and to reimburse those persons for certain expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The securities may or may
not be listed on a national securities exchange. To facilitate the offering of securities, certain persons participating in the offering
may engage in transactions that stabilize, maintain or otherwise affect the price of the securities. This may include over-allotments
or short sales of the securities, which involve the sale by persons participating in the offering of more securities than were sold to
them. In these circumstances, these persons would cover such over-allotments or short positions by making purchases in the open market
or by exercising their over-allotment option, if any. In addition, these persons may stabilize or maintain the price of the securities
by bidding for or purchasing securities in the open market or by imposing penalty bids, whereby selling concessions allowed to dealers
participating in the offering may be reclaimed if securities sold by them are repurchased in connection with stabilization transactions.
The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above that which might
otherwise prevail in the open market. These transactions may be discontinued at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If indicated in the applicable
prospectus supplement, underwriters or other persons acting as agents may be authorized to solicit offers by institutions or other suitable
purchasers to purchase the securities at the public offering price set forth in the prospectus supplement, pursuant to delayed delivery
contracts providing for payment and delivery on the date or dates stated in the prospectus supplement. These purchasers may include,
among others, commercial and savings banks, insurance companies, pension funds, investment companies and educational and charitable institutions.
Delayed delivery contracts will be subject to the condition that the purchase of the securities covered by the delayed delivery contracts
will not at the time of delivery be prohibited under the laws of any jurisdiction in the United States to which the purchaser is subject.
The underwriters and agents will not have any responsibility with respect to the validity or performance of these contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may engage in at-the-market
offerings into an existing trading market in accordance with rule&nbsp;415(a)(4)&nbsp;under the Securities Act. In addition, we may enter
into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated
transactions. If the applicable prospectus supplement so indicates, in connection with those derivatives, the third parties may sell
securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third
party may use securities pledged by us, or borrowed from us or others to settle those sales or to close out any related open borrowings
of common stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings
of our common stock. In addition, we may loan or pledge securities to a financial institution or other third party that in turn may sell
the securities using this prospectus and an applicable prospectus supplement. Such financial institution or other third party may transfer
its economic short position to investors in our securities or in connection with a concurrent offering of other securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The underwriters, dealers
and agents may engage in transactions with us, or perform services for us, in the ordinary course of business for which they receive
compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_014"></A>Legal
Matters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise indicated
in the applicable prospectus supplement, certain legal matters in connection with the offering and the validity of the securities offered
by this prospectus, and any supplement thereto, will be passed upon by O&rsquo;Melveny&nbsp;&amp; Myers LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_015"></A>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial statements and management&rsquo;s
assessment of the effectiveness of internal control over financial reporting (which is included in Management&rsquo;s Annual Report on
Internal Control over Financial Reporting) incorporated in this Prospectus by reference to the <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1065059/000106505923000009/leu-20221231.htm">Annual
Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2022</A> have been so incorporated in reliance on the report of PricewaterhouseCoopers
LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to $200,000,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<IMG SRC="tm2514263d1_424b5img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Centrus Energy Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Class&nbsp;A Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="border-top: Black 1pt solid; font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1pt solid"><B>Prospectus Supplement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>B. Riley Securities</B></FONT></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Lake Street</B></FONT></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Roth Capital Partners</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">May&nbsp;9, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 45; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2514263d1_424b5img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2514263d1_424b5img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "0 /H# 2(  A$! Q$!_\0
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MZ&K=-1%0;5SC.>3GK3J](]4**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ JM(54O(Q4*"!R.<[5/!_S^M2R%@%(SPV3CDD;6X^F<9KYZ_:/^+-_\
M&O@=\4OBG9Z/<:U>>!?#-SK5GIEL/,ENKD2VEK"#&8I?W,3W(FG\M&(BBE8
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M.IR6:KQ44HVGS<JBEHX/2S1K44R,DH">3SG/L2*?7M'LA1110 4444 %%%%
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MEG!&'SRGBL?_ &BL'3JNJYIM.-%U(N,>??2-D]&]]S[]_P""3'[4GC;]MO\
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M5+C49?$-SK5Z_BK4],^(/A#PWJT>DV@UI#X8>W\4"UL1,EG)9VVGM(K7,B.
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# /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
